id	sid	tid	token	lemma	pos
iajs-877	1	1	ibn	ibn	PROPN
iajs-877	1	2	alhaitham	alhaitham	NOUN
iajs-877	1	3	j.	j.	PROPN
iajs-877	2	1	fo	fo	ADP
iajs-877	2	2	r	r	NOUN
iajs-877	2	3	pure	pure	ADJ
iajs-877	2	4	&	&	CCONJ
iajs-877	2	5	appl	appl	PROPN
iajs-877	2	6	.	.	PUNCT
iajs-877	3	1	sci	sci	PROPN
iajs-877	3	2	.	.	PROPN
iajs-877	4	1	vo	vo	INTJ
iajs-877	4	2	l.24	l.24	PROPN
iajs-877	4	3	(	(	PUNCT
iajs-877	4	4	1	1	NUM
iajs-877	4	5	)	)	PUNCT
iajs-877	4	6	2011	2011	NUM
iajs-877	4	7	comparison	comparison	NOUN
iajs-877	4	8	in	in	ADP
iajs-877	4	9	some	some	DET
iajs-877	4	10	biochemical	biochemical	ADJ
iajs-877	4	11	and	and	CCONJ
iajs-877	4	12	hematological	hematological	ADJ
iajs-877	4	13	tests	test	NOUN
iajs-877	4	14	between	between	ADP
iajs-877	4	15	chronic	chronic	ADJ
iajs-877	4	16	hepatitis	hepatitis	PROPN
iajs-877	4	17	b	b	PROPN
iajs-877	4	18	and	and	CCONJ
iajs-877	4	19	c	c	PROPN
iajs-877	4	20	received	receive	VERB
iajs-877	4	21	in	in	ADP
iajs-877	4	22	:	:	PUNCT
iajs-877	4	23	7	7	NUM
iajs-877	4	24	april	april	PROPN
iajs-877	4	25	2010	2010	NUM
iajs-877	4	26	accepted	accept	VERB
iajs-877	4	27	in	in	ADP
iajs-877	4	28	:	:	PUNCT
iajs-877	4	29	9	9	NUM
iajs-877	4	30	november	november	PROPN
iajs-877	4	31	2010	2010	NUM
iajs-877	4	32	r.h	r.h	PROPN
iajs-877	4	33	.	.	PROPN
iajs-877	4	34	hussein	hussein	PROPN
iajs-877	4	35	college	college	PROPN
iajs-877	4	36	of	of	ADP
iajs-877	4	37	health	health	PROPN
iajs-877	4	38	and	and	CCONJ
iajs-877	4	39	medical	medical	ADJ
iajs-877	4	40	technology	technology	NOUN
iajs-877	4	41	abstract	abstract	ADJ
iajs-877	4	42	chronic	chronic	ADJ
iajs-877	4	43	viral	viral	ADJ
iajs-877	4	44	hepatitis	hepatitis	NOUN
iajs-877	4	45	is	be	AUX
iajs-877	4	46	an	an	DET
iajs-877	4	47	important	important	ADJ
iajs-877	4	48	health	health	NOUN
iajs-877	4	49	problem	problem	NOUN
iajs-877	4	50	in	in	ADP
iajs-877	4	51	the	the	DET
iajs-877	4	52	world	world	NOUN
iajs-877	4	53	,	,	PUNCT
iajs-877	4	54	where	where	SCONJ
iajs-877	4	55	hepatitis	hepatitis	PROPN
iajs-877	4	56	b	b	PROPN
iajs-877	4	57	virus	virus	NOUN
iajs-877	4	58	(	(	PUNCT
iajs-877	4	59	hbv	hbv	NOUN
iajs-877	4	60	)	)	PUNCT
iajs-877	4	61	or	or	CCONJ
iajs-877	4	62	hepatitis	hepatitis	PROPN
iajs-877	4	63	c	c	PROPN
iajs-877	4	64	virus	virus	NOUN
iajs-877	4	65	(	(	PUNCT
iajs-877	4	66	hcv	hcv	NOUN
iajs-877	4	67	)	)	PUNCT
iajs-877	4	68	infections	infection	NOUN
iajs-877	4	69	are	be	AUX
iajs-877	4	70	the	the	DET
iajs-877	4	71	main	main	ADJ
iajs-877	4	72	causes	cause	NOUN
iajs-877	4	73	of	of	ADP
iajs-877	4	74	liver	liver	NOUN
iajs-877	4	75	insufficiency	insufficiency	NOUN
iajs-877	4	76	.	.	PUNCT
iajs-877	5	1	the	the	DET
iajs-877	5	2	study	study	NOUN
iajs-877	5	3	included	include	VERB
iajs-877	5	4	100	100	NUM
iajs-877	5	5	blood	blood	NOUN
iajs-877	5	6	samples	sample	NOUN
iajs-877	5	7	from	from	ADP
iajs-877	5	8	patients	patient	NOUN
iajs-877	5	9	with	with	ADP
iajs-877	5	10	chronic	chronic	ADJ
iajs-877	5	11	viral	viral	ADJ
iajs-877	5	12	hepatitis	hepatitis	NOUN
iajs-877	5	13	,	,	PUNCT
iajs-877	5	14	fifty	fifty	NUM
iajs-877	5	15	of	of	ADP
iajs-877	5	16	them	they	PRON
iajs-877	5	17	with	with	ADP
iajs-877	5	18	hbv	hbv	NOUN
iajs-877	5	19	infection	infection	NOUN
iajs-877	5	20	and	and	CCONJ
iajs-877	5	21	50	50	NUM
iajs-877	5	22	with	with	ADP
iajs-877	5	23	hcv	hcv	NOUN
iajs-877	5	24	infection	infection	NOUN
iajs-877	5	25	.	.	PUNCT
iajs-877	6	1	twenty	twenty	NUM
iajs-877	6	2	apparently	apparently	ADV
iajs-877	6	3	healthy	healthy	ADJ
iajs-877	6	4	age	age	NOUN
iajs-877	6	5	and	and	CCONJ
iajs-877	6	6	gender	gender	NOUN
iajs-877	6	7	matched	match	VERB
iajs-877	6	8	subjects	subject	NOUN
iajs-877	6	9	were	be	AUX
iajs-877	6	10	included	include	VERB
iajs-877	6	11	as	as	ADP
iajs-877	6	12	a	a	DET
iajs-877	6	13	control	control	NOUN
iajs-877	6	14	group	group	NOUN
iajs-877	6	15	.	.	PUNCT
iajs-877	7	1	out	out	ADP
iajs-877	7	2	of	of	ADP
iajs-877	7	3	the	the	DET
iajs-877	7	4	50	50	NUM
iajs-877	7	5	patients	patient	NOUN
iajs-877	7	6	with	with	ADP
iajs-877	7	7	hbv	hbv	NOUN
iajs-877	7	8	,	,	PUNCT
iajs-877	7	9	36(72	36(72	NUM
iajs-877	7	10	%	%	NOUN
iajs-877	7	11	)	)	PUNCT
iajs-877	7	12	were	be	AUX
iajs-877	7	13	males	male	NOUN
iajs-877	7	14	and	and	CCONJ
iajs-877	7	15	14(28	14(28	NUM
iajs-877	7	16	%	%	NOUN
iajs-877	7	17	)	)	PUNCT
iajs-877	7	18	were	be	AUX
iajs-877	7	19	females	female	NOUN
iajs-877	7	20	.	.	PUNCT
iajs-877	8	1	thirty	thirty	NUM
iajs-877	8	2	two	two	NUM
iajs-877	8	3	(	(	PUNCT
iajs-877	8	4	64	64	NUM
iajs-877	8	5	%	%	NOUN
iajs-877	8	6	)	)	PUNCT
iajs-877	8	7	patients	patient	NOUN
iajs-877	8	8	with	with	ADP
iajs-877	8	9	hcv	hcv	PROPN
iajs-877	8	10	were	be	AUX
iajs-877	8	11	males	male	NOUN
iajs-877	8	12	and	and	CCONJ
iajs-877	8	13	18(36	18(36	NUM
iajs-877	8	14	%	%	NOUN
iajs-877	8	15	)	)	PUNCT
iajs-877	8	16	were	be	AUX
iajs-877	8	17	females	female	NOUN
iajs-877	8	18	.	.	PUNCT
iajs-877	9	1	the	the	DET
iajs-877	9	2	mean	mean	ADJ
iajs-877	9	3	age	age	NOUN
iajs-877	9	4	for	for	ADP
iajs-877	9	5	hbv	hbv	NOUN
iajs-877	9	6	patients	patient	NOUN
iajs-877	9	7	was	be	AUX
iajs-877	9	8	36.9	36.9	NUM
iajs-877	9	9	±	±	NUM
iajs-877	9	10	15.8	15.8	NUM
iajs-877	9	11	year	year	NOUN
iajs-877	9	12	and	and	CCONJ
iajs-877	9	13	for	for	ADP
iajs-877	9	14	hcv	hcv	NOUN
iajs-877	9	15	patients	patient	NOUN
iajs-877	9	16	it	it	PRON
iajs-877	9	17	was	be	AUX
iajs-877	9	18	39.9	39.9	NUM
iajs-877	9	19	±14.2	±14.2	NUM
iajs-877	9	20	year	year	NOUN
iajs-877	9	21	.	.	PUNCT
iajs-877	10	1	the	the	DET
iajs-877	10	2	results	result	NOUN
iajs-877	10	3	of	of	ADP
iajs-877	10	4	the	the	DET
iajs-877	10	5	liver	liver	NOUN
iajs-877	10	6	function	function	NOUN
iajs-877	10	7	tests	test	NOUN
iajs-877	10	8	showed	show	VERB
iajs-877	10	9	no	no	DET
iajs-877	10	10	significant	significant	ADJ
iajs-877	10	11	difference	difference	NOUN
iajs-877	10	12	between	between	ADP
iajs-877	10	13	hbv	hbv	NOUN
iajs-877	10	14	and	and	CCONJ
iajs-877	10	15	hcv	hcv	NOUN
iajs-877	10	16	patients	patient	NOUN
iajs-877	10	17	.	.	PUNCT
iajs-877	11	1	both	both	PRON
iajs-877	11	2	of	of	ADP
iajs-877	11	3	hbv	hbv	NOUN
iajs-877	11	4	and	and	CCONJ
iajs-877	11	5	hcv	hcv	NOUN
iajs-877	11	6	patients	patient	NOUN
iajs-877	11	7	showed	show	VERB
iajs-877	11	8	a	a	DET
iajs-877	11	9	significant	significant	ADJ
iajs-877	11	10	difference	difference	NOUN
iajs-877	11	11	regarding	regard	VERB
iajs-877	11	12	liver	liver	NOUN
iajs-877	11	13	function	function	NOUN
iajs-877	11	14	tests	test	NOUN
iajs-877	11	15	when	when	SCONJ
iajs-877	11	16	compared	compare	VERB
iajs-877	11	17	with	with	ADP
iajs-877	11	18	the	the	DET
iajs-877	11	19	control	control	NOUN
iajs-877	11	20	group	group	NOUN
iajs-877	11	21	.	.	PUNCT
iajs-877	12	1	total	total	ADJ
iajs-877	12	2	white	white	ADJ
iajs-877	12	3	blood	blood	NOUN
iajs-877	12	4	cell	cell	NOUN
iajs-877	12	5	count	count	NOUN
iajs-877	12	6	and	and	CCONJ
iajs-877	12	7	hemoglobin	hemoglobin	NOUN
iajs-877	12	8	concentration	concentration	NOUN
iajs-877	12	9	were	be	AUX
iajs-877	12	10	lower	low	ADJ
iajs-877	12	11	(	(	PUNCT
iajs-877	12	12	4296±	4296±	NUM
iajs-877	12	13	1050.9	1050.9	NUM
iajs-877	12	14	cell/	cell/	NUM
iajs-877	12	15	mm3	mm3	NOUN
iajs-877	12	16	and	and	CCONJ
iajs-877	12	17	10.9	10.9	NUM
iajs-877	12	18	±	±	NUM
iajs-877	12	19	2.2g	2.2g	PROPN
iajs-877	12	20	/	/	SYM
iajs-877	12	21	dl	dl	PROPN
iajs-877	12	22	respectively	respectively	ADV
iajs-877	12	23	)	)	PUNCT
iajs-877	12	24	in	in	ADP
iajs-877	12	25	hcv	hcv	NOUN
iajs-877	12	26	patients	patient	NOUN
iajs-877	12	27	than	than	ADP
iajs-877	12	28	those	those	PRON
iajs-877	12	29	in	in	ADP
iajs-877	12	30	hbv	hbv	NOUN
iajs-877	12	31	patients	patient	NOUN
iajs-877	12	32	(	(	PUNCT
iajs-877	12	33	6224	6224	NUM
iajs-877	12	34	±	±	NUM
iajs-877	12	35	1749.1	1749.1	NUM
iajs-877	12	36	cell	cell	NOUN
iajs-877	12	37	/mm3	/mm3	NOUN
iajs-877	12	38	and	and	CCONJ
iajs-877	12	39	13.4	13.4	NUM
iajs-877	12	40	±1.3	±1.3	PROPN
iajs-877	12	41	g	g	PROPN
iajs-877	12	42	/	/	SYM
iajs-877	12	43	dl	dl	PROPN
iajs-877	12	44	)	)	PUNCT
iajs-877	12	45	with	with	ADP
iajs-877	12	46	a	a	DET
iajs-877	12	47	significant	significant	ADJ
iajs-877	12	48	difference	difference	NOUN
iajs-877	12	49	.	.	PUNCT
iajs-877	13	1	however	however	ADV
iajs-877	13	2	there	there	PRON
iajs-877	13	3	was	be	VERB
iajs-877	13	4	no	no	DET
iajs-877	13	5	significant	significant	ADJ
iajs-877	13	6	difference	difference	NOUN
iajs-877	13	7	between	between	ADP
iajs-877	13	8	hbv	hbv	NOUN
iajs-877	13	9	patients	patient	NOUN
iajs-877	13	10	and	and	CCONJ
iajs-877	13	11	control	control	NOUN
iajs-877	13	12	regarding	regard	VERB
iajs-877	13	13	total	total	ADJ
iajs-877	13	14	white	white	ADJ
iajs-877	13	15	blood	blood	NOUN
iajs-877	13	16	cell	cell	NOUN
iajs-877	13	17	count	count	NOUN
iajs-877	13	18	and	and	CCONJ
iajs-877	13	19	hemoglobin	hemoglobin	NOUN
iajs-877	13	20	concentration	concentration	NOUN
iajs-877	13	21	.	.	PUNCT
iajs-877	14	1	aim	aim	NOUN
iajs-877	14	2	of	of	ADP
iajs-877	14	3	study	study	NOUN
iajs-877	14	4	:	:	PUNCT
iajs-877	14	5	to	to	PART
iajs-877	14	6	compare	compare	VERB
iajs-877	14	7	between	between	ADP
iajs-877	14	8	chronic	chronic	ADJ
iajs-877	14	9	hepatitis	hepatitis	PROPN
iajs-877	14	10	b	b	PROPN
iajs-877	14	11	,	,	PUNCT
iajs-877	14	12	chronic	chronic	ADJ
iajs-877	14	13	hepatitis	hepatitis	PROPN
iajs-877	14	14	c	c	PROPN
iajs-877	14	15	and	and	CCONJ
iajs-877	14	16	control	control	NOUN
iajs-877	14	17	regarding	regard	VERB
iajs-877	14	18	some	some	DET
iajs-877	14	19	hematological	hematological	ADJ
iajs-877	14	20	and	and	CCONJ
iajs-877	14	21	biochemical	biochemical	ADJ
iajs-877	14	22	parameters	parameter	NOUN
iajs-877	14	23	.	.	PUNCT
iajs-877	15	1	key	key	ADJ
iajs-877	15	2	words	word	NOUN
iajs-877	15	3	:	:	PUNCT
iajs-877	15	4	chronic	chronic	ADJ
iajs-877	15	5	hepatitis	hepatitis	PROPN
iajs-877	15	6	b	b	PROPN
iajs-877	15	7	and	and	CCONJ
iajs-877	15	8	c	c	PROPN
iajs-877	15	9	introduction	introduction	NOUN
iajs-877	15	10	viral	viral	ADJ
iajs-877	15	11	hepatitis	hepatitis	NOUN
iajs-877	15	12	is	be	AUX
iajs-877	15	13	a	a	DET
iajs-877	15	14	major	major	ADJ
iajs-877	15	15	global	global	ADJ
iajs-877	15	16	public	public	ADJ
iajs-877	15	17	health	health	NOUN
iajs-877	15	18	concern	concern	NOUN
iajs-877	15	19	,	,	PUNCT
iajs-877	15	20	it	it	PRON
iajs-877	15	21	is	be	AUX
iajs-877	15	22	a	a	DET
iajs-877	15	23	source	source	NOUN
iajs-877	15	24	of	of	ADP
iajs-877	15	25	substantial	substantial	ADJ
iajs-877	15	26	morbidity	morbidity	NOUN
iajs-877	15	27	and	and	CCONJ
iajs-877	15	28	mortality	mortality	NOUN
iajs-877	15	29	around	around	ADP
iajs-877	15	30	the	the	DET
iajs-877	15	31	world	world	NOUN
iajs-877	15	32	.	.	PUNCT
iajs-877	16	1	viral	viral	ADJ
iajs-877	16	2	hepatitis	hepatitis	NOUN
iajs-877	16	3	is	be	AUX
iajs-877	16	4	caused	cause	VERB
iajs-877	16	5	by	by	ADP
iajs-877	16	6	at	at	ADV
iajs-877	16	7	least	least	ADV
iajs-877	16	8	five	five	NUM
iajs-877	16	9	distinct	distinct	ADJ
iajs-877	16	10	viruses	virus	NOUN
iajs-877	16	11	a	a	DET
iajs-877	16	12	,	,	PUNCT
iajs-877	16	13	b	b	NOUN
iajs-877	16	14	,	,	PUNCT
iajs-877	16	15	c	c	NOUN
iajs-877	16	16	,	,	PUNCT
iajs-877	16	17	d	d	NOUN
iajs-877	16	18	,	,	PUNCT
iajs-877	16	19	or	or	CCONJ
iajs-877	16	20	e.	e.	PROPN
iajs-877	16	21	each	each	PRON
iajs-877	16	22	belongs	belong	VERB
iajs-877	16	23	to	to	ADP
iajs-877	16	24	an	an	DET
iajs-877	16	25	entirely	entirely	ADV
iajs-877	16	26	different	different	ADJ
iajs-877	16	27	family	family	NOUN
iajs-877	16	28	of	of	ADP
iajs-877	16	29	viruses	virus	NOUN
iajs-877	16	30	,	,	PUNCT
iajs-877	16	31	and	and	CCONJ
iajs-877	16	32	they	they	PRON
iajs-877	16	33	have	have	VERB
iajs-877	16	34	very	very	ADV
iajs-877	16	35	little	little	ADJ
iajs-877	16	36	in	in	ADP
iajs-877	16	37	common	common	ADJ
iajs-877	16	38	except	except	SCONJ
iajs-877	16	39	the	the	DET
iajs-877	16	40	target	target	NOUN
iajs-877	16	41	organ	organ	NOUN
iajs-877	16	42	,	,	PUNCT
iajs-877	16	43	they	they	PRON
iajs-877	16	44	affect	affect	VERB
iajs-877	16	45	the	the	DET
iajs-877	16	46	liver	liver	NOUN
iajs-877	16	47	and	and	CCONJ
iajs-877	16	48	a	a	DET
iajs-877	16	49	certain	certain	ADJ
iajs-877	16	50	degree	degree	NOUN
iajs-877	16	51	of	of	ADP
iajs-877	16	52	shared	shared	ADJ
iajs-877	16	53	epidemiology	epidemiology	NOUN
iajs-877	16	54	.	.	PUNCT
iajs-877	17	1	[	[	X
iajs-877	17	2	1	1	X
iajs-877	17	3	]	]	PUNCT
iajs-877	17	4	chronic	chronic	ADJ
iajs-877	17	5	hepatitis	hepatitis	PROPN
iajs-877	17	6	b	b	PROPN
iajs-877	17	7	and	and	CCONJ
iajs-877	17	8	chronic	chronic	ADJ
iajs-877	17	9	hepatitis	hepatitis	NOUN
iajs-877	17	10	c	c	PROPN
iajs-877	17	11	are	be	AUX
iajs-877	17	12	progressive	progressive	ADJ
iajs-877	17	13	diseases	disease	NOUN
iajs-877	17	14	linked	link	VERB
iajs-877	17	15	to	to	ADP
iajs-877	17	16	the	the	DET
iajs-877	17	17	development	development	NOUN
iajs-877	17	18	of	of	ADP
iajs-877	17	19	cirrhosis	cirrhosis	NOUN
iajs-877	17	20	and	and	CCONJ
iajs-877	17	21	hepatocellular	hepatocellular	ADJ
iajs-877	17	22	carcinoma	carcinoma	NOUN
iajs-877	17	23	.	.	PUNCT
iajs-877	18	1	chronic	chronic	ADJ
iajs-877	18	2	liver	liver	NOUN
iajs-877	18	3	disease	disease	NOUN
iajs-877	18	4	is	be	AUX
iajs-877	18	5	accompanied	accompany	VERB
iajs-877	18	6	by	by	ADP
iajs-877	18	7	derangement	derangement	NOUN
iajs-877	18	8	of	of	ADP
iajs-877	18	9	hepatocyte	hepatocyte	NOUN
iajs-877	18	10	function	function	NOUN
iajs-877	18	11	including	include	VERB
iajs-877	18	12	the	the	DET
iajs-877	18	13	synthesis	synthesis	NOUN
iajs-877	18	14	of	of	ADP
iajs-877	18	15	haemostastic	haemostastic	ADJ
iajs-877	18	16	factors	factor	NOUN
iajs-877	18	17	.	.	PUNCT
iajs-877	19	1	[	[	X
iajs-877	19	2	2	2	NUM
iajs-877	19	3	]	]	SYM
iajs-877	19	4	four	four	NUM
iajs-877	19	5	separate	separate	ADJ
iajs-877	19	6	liver	liver	NOUN
iajs-877	19	7	enzymes	enzyme	NOUN
iajs-877	19	8	are	be	AUX
iajs-877	19	9	included	include	VERB
iajs-877	19	10	on	on	ADP
iajs-877	19	11	most	most	ADV
iajs-877	19	12	routine	routine	ADJ
iajs-877	19	13	laboratory	laboratory	NOUN
iajs-877	19	14	tests	test	NOUN
iajs-877	19	15	.	.	PUNCT
iajs-877	20	1	they	they	PRON
iajs-877	20	2	are	be	AUX
iajs-877	20	3	aspartate	aspartate	ADJ
iajs-877	20	4	aminotransferase	aminotransferase	NOUN
iajs-877	20	5	(	(	PUNCT
iajs-877	20	6	ast	ast	NOUN
iajs-877	20	7	or	or	CCONJ
iajs-877	20	8	sgot	sgot	VERB
iajs-877	20	9	)	)	PUNCT
iajs-877	20	10	and	and	CCONJ
iajs-877	20	11	alanine	alanine	NOUN
iajs-877	20	12	aminotransferase	aminotransferase	PROPN
iajs-877	20	13	(	(	PUNCT
iajs-877	20	14	alt	alt	VERB
iajs-877	20	15	or	or	CCONJ
iajs-877	20	16	sgpt	sgpt	NOUN
iajs-877	20	17	)	)	PUNCT
iajs-877	20	18	,	,	PUNCT
iajs-877	20	19	which	which	PRON
iajs-877	20	20	are	be	AUX
iajs-877	20	21	known	know	VERB
iajs-877	20	22	together	together	ADV
iajs-877	20	23	as	as	ADP
iajs-877	20	24	transaminases	transaminase	NOUN
iajs-877	20	25	;	;	PUNCT
iajs-877	20	26	and	and	CCONJ
iajs-877	20	27	alkaline	alkaline	ADJ
iajs-877	20	28	phosphatase	phosphatase	NOUN
iajs-877	20	29	(	(	PUNCT
iajs-877	20	30	alp	alp	PROPN
iajs-877	20	31	)	)	PUNCT
iajs-877	20	32	and	and	CCONJ
iajs-877	20	33	gammaglutamyl	gammaglutamyl	NOUN
iajs-877	20	34	transferase	transferase	NOUN
iajs-877	20	35	(	(	PUNCT
iajs-877	20	36	ggt	ggt	NOUN
iajs-877	20	37	)	)	PUNCT
iajs-877	20	38	,	,	PUNCT
iajs-877	20	39	which	which	PRON
iajs-877	20	40	are	be	AUX
iajs-877	20	41	known	know	VERB
iajs-877	20	42	together	together	ADV
iajs-877	20	43	as	as	ADP
iajs-877	20	44	cholestatic	cholestatic	ADJ
iajs-877	20	45	liver	liver	NOUN
iajs-877	20	46	enzymes	enzyme	NOUN
iajs-877	20	47	.	.	PUNCT
iajs-877	21	1	elevations	elevation	NOUN
iajs-877	21	2	of	of	ADP
iajs-877	21	3	these	these	DET
iajs-877	21	4	enzymes	enzyme	NOUN
iajs-877	21	5	can	can	AUX
iajs-877	21	6	indicate	indicate	VERB
iajs-877	21	7	the	the	DET
iajs-877	21	8	presence	presence	NOUN
iajs-877	21	9	of	of	ADP
iajs-877	21	10	liver	liver	NOUN
iajs-877	21	11	disease	disease	NOUN
iajs-877	21	12	.	.	PUNCT
iajs-877	22	1	in	in	ADP
iajs-877	22	2	cases	case	NOUN
iajs-877	22	3	of	of	ADP
iajs-877	22	4	acute	acute	ADJ
iajs-877	22	5	viral	viral	ADJ
iajs-877	22	6	hepatitis	hepatitis	NOUN
iajs-877	22	7	,	,	PUNCT
iajs-877	22	8	aminotransferase	aminotransferase	PROPN
iajs-877	22	9	levels	level	NOUN
iajs-877	22	10	usually	usually	ADV
iajs-877	22	11	peak	peak	VERB
iajs-877	22	12	before	before	SCONJ
iajs-877	22	13	jaundice	jaundice	NOUN
iajs-877	22	14	appears	appear	VERB
iajs-877	22	15	and	and	CCONJ
iajs-877	22	16	have	have	VERB
iajs-877	22	17	a	a	DET
iajs-877	22	18	more	more	ADV
iajs-877	22	19	gradual	gradual	ADJ
iajs-877	22	20	decrease	decrease	NOUN
iajs-877	22	21	thereafter	thereafter	ADV
iajs-877	22	22	,	,	PUNCT
iajs-877	22	23	and	and	CCONJ
iajs-877	22	24	there	there	PRON
iajs-877	22	25	is	be	VERB
iajs-877	22	26	a	a	DET
iajs-877	22	27	greater	great	ADJ
iajs-877	22	28	increase	increase	NOUN
iajs-877	22	29	in	in	ADP
iajs-877	22	30	serum	serum	NOUN
iajs-877	22	31	bilirubin	bilirubin	NOUN
iajs-877	22	32	levels	level	NOUN
iajs-877	22	33	.	.	PUNCT
iajs-877	23	1	the	the	DET
iajs-877	23	2	entire	entire	ADJ
iajs-877	23	3	alphabet	alphabet	NOUN
iajs-877	23	4	of	of	ADP
iajs-877	23	5	viral	viral	ADJ
iajs-877	23	6	hepatitis	hepatitis	NOUN
iajs-877	23	7	(	(	PUNCT
iajs-877	23	8	a	a	PRON
iajs-877	23	9	,	,	PUNCT
iajs-877	23	10	b	b	NOUN
iajs-877	23	11	,	,	PUNCT
iajs-877	23	12	c	c	NOUN
iajs-877	23	13	,	,	PUNCT
iajs-877	23	14	d	d	NOUN
iajs-877	23	15	and	and	CCONJ
iajs-877	23	16	e	e	X
iajs-877	23	17	)	)	PUNCT
iajs-877	23	18	may	may	AUX
iajs-877	23	19	be	be	AUX
iajs-877	23	20	responsible	responsible	ADJ
iajs-877	23	21	for	for	ADP
iajs-877	23	22	a	a	DET
iajs-877	23	23	marked	mark	VERB
iajs-877	23	24	increase	increase	NOUN
iajs-877	23	25	in	in	ADP
iajs-877	23	26	aminotransferase	aminotransferase	PROPN
iajs-877	23	27	levels	level	NOUN
iajs-877	23	28	,	,	PUNCT
iajs-877	23	29	although	although	SCONJ
iajs-877	23	30	the	the	DET
iajs-877	23	31	increase	increase	NOUN
iajs-877	23	32	associated	associate	VERB
iajs-877	23	33	with	with	ADP
iajs-877	23	34	hepatitis	hepatitis	PROPN
iajs-877	23	35	c	c	PROPN
iajs-877	23	36	infection	infection	NOUN
iajs-877	23	37	tends	tend	VERB
iajs-877	23	38	to	to	PART
iajs-877	23	39	be	be	AUX
iajs-877	23	40	ibn	ibn	PROPN
iajs-877	23	41	alhaitham	alhaitham	NOUN
iajs-877	24	1	j.	j.	PROPN
iajs-877	25	1	fo	fo	ADP
iajs-877	25	2	r	r	NOUN
iajs-877	25	3	pure	pure	ADJ
iajs-877	25	4	&	&	CCONJ
iajs-877	25	5	appl	appl	PROPN
iajs-877	25	6	.	.	PUNCT
iajs-877	26	1	sci	sci	PROPN
iajs-877	26	2	.	.	PROPN
iajs-877	27	1	vo	vo	INTJ
iajs-877	28	1	l.24	l.24	PROPN
iajs-877	28	2	(	(	PUNCT
iajs-877	28	3	1	1	NUM
iajs-877	28	4	)	)	PUNCT
iajs-877	28	5	2011	2011	NUM
iajs-877	28	6	more	more	ADV
iajs-877	28	7	modest	modest	ADJ
iajs-877	28	8	than	than	ADP
iajs-877	28	9	that	that	PRON
iajs-877	28	10	associated	associate	VERB
iajs-877	28	11	with	with	ADP
iajs-877	28	12	hepatitis	hepatitis	PROPN
iajs-877	28	13	a	a	PRON
iajs-877	28	14	or	or	CCONJ
iajs-877	28	15	b.	b.	NOUN
iajs-877	28	16	liver	liver	NOUN
iajs-877	28	17	and	and	CCONJ
iajs-877	28	18	bone	bone	NOUN
iajs-877	28	19	diseases	disease	NOUN
iajs-877	28	20	are	be	AUX
iajs-877	28	21	the	the	DET
iajs-877	28	22	most	most	ADV
iajs-877	28	23	common	common	ADJ
iajs-877	28	24	causes	cause	NOUN
iajs-877	28	25	of	of	ADP
iajs-877	28	26	pathological	pathological	ADJ
iajs-877	28	27	elevation	elevation	NOUN
iajs-877	28	28	of	of	ADP
iajs-877	28	29	alp	alp	PROPN
iajs-877	28	30	levels	level	NOUN
iajs-877	28	31	,	,	PUNCT
iajs-877	28	32	although	although	SCONJ
iajs-877	28	33	alp	alp	PROPN
iajs-877	28	34	may	may	AUX
iajs-877	28	35	originate	originate	VERB
iajs-877	28	36	from	from	ADP
iajs-877	28	37	other	other	ADJ
iajs-877	28	38	tissue	tissue	NOUN
iajs-877	28	39	,	,	PUNCT
iajs-877	28	40	such	such	ADJ
iajs-877	28	41	as	as	ADP
iajs-877	28	42	the	the	DET
iajs-877	28	43	placenta	placenta	NOUN
iajs-877	28	44	,	,	PUNCT
iajs-877	28	45	kidneys	kidney	NOUN
iajs-877	28	46	or	or	CCONJ
iajs-877	28	47	intestines	intestine	NOUN
iajs-877	28	48	,	,	PUNCT
iajs-877	28	49	or	or	CCONJ
iajs-877	28	50	from	from	ADP
iajs-877	28	51	leukocytes.[3	leukocytes.[3	PROPN
iajs-877	28	52	]	]	PUNCT
iajs-877	28	53	the	the	DET
iajs-877	28	54	epidemiology	epidemiology	NOUN
iajs-877	28	55	of	of	ADP
iajs-877	28	56	hbv	hbv	NOUN
iajs-877	28	57	and	and	CCONJ
iajs-877	28	58	hcv	hcv	PROPN
iajs-877	28	59	infection	infection	NOUN
iajs-877	28	60	varies	vary	VERB
iajs-877	28	61	according	accord	VERB
iajs-877	28	62	to	to	ADP
iajs-877	28	63	geographical	geographical	ADJ
iajs-877	28	64	area	area	NOUN
iajs-877	28	65	.	.	PUNCT
iajs-877	29	1	hbv	hbv	NOUN
iajs-877	29	2	infection	infection	NOUN
iajs-877	29	3	is	be	AUX
iajs-877	29	4	a	a	DET
iajs-877	29	5	serious	serious	ADJ
iajs-877	29	6	global	global	ADJ
iajs-877	29	7	health	health	NOUN
iajs-877	29	8	problem	problem	NOUN
iajs-877	29	9	,	,	PUNCT
iajs-877	29	10	with	with	ADP
iajs-877	29	11	two	two	NUM
iajs-877	29	12	billion	billion	NUM
iajs-877	29	13	people	people	NOUN
iajs-877	29	14	infected	infect	VERB
iajs-877	29	15	worldwide	worldwide	ADV
iajs-877	29	16	,	,	PUNCT
iajs-877	29	17	and	and	CCONJ
iajs-877	29	18	350	350	NUM
iajs-877	29	19	million	million	NUM
iajs-877	29	20	suffering	suffering	NOUN
iajs-877	29	21	from	from	ADP
iajs-877	29	22	chronic	chronic	ADJ
iajs-877	29	23	hbv	hbv	NOUN
iajs-877	29	24	infection	infection	NOUN
iajs-877	29	25	.	.	PUNCT
iajs-877	30	1	chronic	chronic	ADJ
iajs-877	30	2	hepatitis	hepatitis	PROPN
iajs-877	30	3	b	b	PROPN
iajs-877	30	4	(	(	PUNCT
iajs-877	30	5	chb	chb	NOUN
iajs-877	30	6	)	)	PUNCT
iajs-877	30	7	affects	affect	VERB
iajs-877	30	8	more	more	ADJ
iajs-877	30	9	than	than	ADP
iajs-877	30	10	400	400	NUM
iajs-877	30	11	million	million	NUM
iajs-877	30	12	people	people	NOUN
iajs-877	30	13	globally	globally	ADV
iajs-877	30	14	,	,	PUNCT
iajs-877	30	15	of	of	ADP
iajs-877	30	16	whom	whom	PRON
iajs-877	30	17	75	75	NUM
iajs-877	30	18	%	%	NOUN
iajs-877	30	19	are	be	AUX
iajs-877	30	20	asians	asian	NOUN
iajs-877	31	1	[	[	X
iajs-877	31	2	4	4	NUM
iajs-877	31	3	]	]	PUNCT
iajs-877	31	4	.	.	PUNCT
iajs-877	32	1	in	in	ADP
iajs-877	32	2	the	the	DET
iajs-877	32	3	middle	middle	PROPN
iajs-877	32	4	east	east	PROPN
iajs-877	32	5	,	,	PUNCT
iajs-877	32	6	hbv	hbv	NOUN
iajs-877	32	7	prevalence	prevalence	NOUN
iajs-877	32	8	has	have	AUX
iajs-877	32	9	altered	alter	VERB
iajs-877	32	10	from	from	ADP
iajs-877	32	11	high	high	ADJ
iajs-877	32	12	to	to	ADP
iajs-877	32	13	intermediate	intermediate	ADJ
iajs-877	32	14	or	or	CCONJ
iajs-877	32	15	low	low	ADJ
iajs-877	32	16	prevalence	prevalence	NOUN
iajs-877	32	17	,	,	PUNCT
iajs-877	32	18	but	but	CCONJ
iajs-877	32	19	hbv	hbv	NOUN
iajs-877	32	20	infection	infection	NOUN
iajs-877	32	21	is	be	AUX
iajs-877	32	22	a	a	DET
iajs-877	32	23	problem	problem	NOUN
iajs-877	32	24	of	of	ADP
iajs-877	32	25	public	public	ADJ
iajs-877	32	26	health	health	NOUN
iajs-877	32	27	,	,	PUNCT
iajs-877	32	28	and	and	CCONJ
iajs-877	32	29	a	a	DET
iajs-877	32	30	major	major	ADJ
iajs-877	32	31	cause	cause	NOUN
iajs-877	32	32	of	of	ADP
iajs-877	32	33	mortality	mortality	NOUN
iajs-877	32	34	and	and	CCONJ
iajs-877	32	35	morbidity	morbidity	NOUN
iajs-877	32	36	particularly	particularly	ADV
iajs-877	32	37	in	in	ADP
iajs-877	32	38	developing	develop	VERB
iajs-877	32	39	countries	country	NOUN
iajs-877	32	40	.	.	PUNCT
iajs-877	33	1	[	[	X
iajs-877	33	2	5	5	NUM
iajs-877	33	3	]	]	PUNCT
iajs-877	33	4	in	in	ADP
iajs-877	33	5	the	the	DET
iajs-877	33	6	middle	middle	PROPN
iajs-877	33	7	east	east	PROPN
iajs-877	33	8	,	,	PUNCT
iajs-877	33	9	bahrain	bahrain	NOUN
iajs-877	33	10	,	,	PUNCT
iajs-877	33	11	iran	iran	PROPN
iajs-877	33	12	,	,	PUNCT
iajs-877	33	13	and	and	CCONJ
iajs-877	33	14	kuwait	kuwait	PROPN
iajs-877	33	15	are	be	AUX
iajs-877	33	16	areas	area	NOUN
iajs-877	33	17	of	of	ADP
iajs-877	33	18	low	low	ADJ
iajs-877	33	19	endemicity	endemicity	NOUN
iajs-877	33	20	,	,	PUNCT
iajs-877	33	21	cyprus	cyprus	PROPN
iajs-877	33	22	,	,	PUNCT
iajs-877	33	23	iraq	iraq	PROPN
iajs-877	33	24	and	and	CCONJ
iajs-877	33	25	the	the	DET
iajs-877	33	26	united	united	PROPN
iajs-877	33	27	arab	arab	PROPN
iajs-877	33	28	emirates	emirates	PROPN
iajs-877	33	29	have	have	VERB
iajs-877	33	30	intermediate	intermediate	ADJ
iajs-877	33	31	endemicity	endemicity	NOUN
iajs-877	33	32	,	,	PUNCT
iajs-877	33	33	and	and	CCONJ
iajs-877	33	34	egypt	egypt	PROPN
iajs-877	33	35	,	,	PUNCT
iajs-877	33	36	jordan	jordan	PROPN
iajs-877	33	37	,	,	PUNCT
iajs-877	33	38	oman	oman	PROPN
iajs-877	33	39	,	,	PUNCT
iajs-877	33	40	palestine	palestine	PROPN
iajs-877	33	41	,	,	PUNCT
iajs-877	33	42	yemen	yemen	PROPN
iajs-877	33	43	and	and	CCONJ
iajs-877	33	44	saudi	saudi	PROPN
iajs-877	33	45	arabia	arabia	PROPN
iajs-877	33	46	have	have	AUX
iajs-877	33	47	high	high	ADJ
iajs-877	33	48	endemicity	endemicity	NOUN
iajs-877	33	49	[	[	X
iajs-877	33	50	6	6	NUM
iajs-877	33	51	]	]	PUNCT
iajs-877	33	52	.	.	PUNCT
iajs-877	34	1	studies	study	NOUN
iajs-877	34	2	in	in	ADP
iajs-877	34	3	the	the	DET
iajs-877	34	4	middle	middle	PROPN
iajs-877	34	5	east	east	PROPN
iajs-877	34	6	show	show	VERB
iajs-877	34	7	the	the	DET
iajs-877	34	8	prevalence	prevalence	NOUN
iajs-877	34	9	of	of	ADP
iajs-877	34	10	hbsag	hbsag	NOUN
iajs-877	34	11	to	to	PART
iajs-877	34	12	range	range	VERB
iajs-877	34	13	from	from	ADP
iajs-877	34	14	3	3	NUM
iajs-877	34	15	%	%	NOUN
iajs-877	34	16	to	to	PART
iajs-877	34	17	11	11	NUM
iajs-877	34	18	%	%	NOUN
iajs-877	34	19	in	in	ADP
iajs-877	34	20	egypt	egypt	PROPN
iajs-877	34	21	,	,	PUNCT
iajs-877	34	22	4	4	NUM
iajs-877	34	23	%	%	NOUN
iajs-877	34	24	to	to	PART
iajs-877	34	25	5	5	NUM
iajs-877	34	26	%	%	NOUN
iajs-877	34	27	in	in	ADP
iajs-877	34	28	iraq	iraq	PROPN
iajs-877	34	29	,	,	PUNCT
iajs-877	34	30	2.6	2.6	NUM
iajs-877	34	31	%	%	NOUN
iajs-877	34	32	to	to	PART
iajs-877	34	33	10	10	NUM
iajs-877	34	34	%	%	NOUN
iajs-877	34	35	in	in	ADP
iajs-877	34	36	jordan	jordan	PROPN
iajs-877	34	37	,	,	PUNCT
iajs-877	34	38	2	2	NUM
iajs-877	34	39	%	%	NOUN
iajs-877	34	40	to	to	PART
iajs-877	34	41	6	6	NUM
iajs-877	34	42	%	%	NOUN
iajs-877	34	43	in	in	ADP
iajs-877	34	44	the	the	DET
iajs-877	34	45	libyan	libyan	ADJ
iajs-877	34	46	arab	arab	PROPN
iajs-877	34	47	jamahiriya	jamahiriya	PROPN
iajs-877	34	48	,	,	PUNCT
iajs-877	34	49	2.3	2.3	NUM
iajs-877	34	50	%	%	NOUN
iajs-877	34	51	to	to	PART
iajs-877	34	52	10	10	NUM
iajs-877	34	53	%	%	NOUN
iajs-877	34	54	in	in	ADP
iajs-877	34	55	oman	oman	NOUN
iajs-877	34	56	,	,	PUNCT
iajs-877	34	57	5	5	NUM
iajs-877	34	58	%	%	NOUN
iajs-877	34	59	to	to	PART
iajs-877	34	60	6	6	NUM
iajs-877	34	61	%	%	NOUN
iajs-877	34	62	in	in	ADP
iajs-877	34	63	palestine	palestine	PROPN
iajs-877	34	64	,	,	PUNCT
iajs-877	34	65	7.4	7.4	NUM
iajs-877	34	66	%	%	NOUN
iajs-877	34	67	to	to	PART
iajs-877	34	68	17	17	NUM
iajs-877	34	69	%	%	NOUN
iajs-877	34	70	in	in	ADP
iajs-877	34	71	saudi	saudi	PROPN
iajs-877	34	72	arabia	arabia	PROPN
iajs-877	34	73	,	,	PUNCT
iajs-877	34	74	16	16	NUM
iajs-877	34	75	%	%	NOUN
iajs-877	34	76	to	to	PART
iajs-877	34	77	20	20	NUM
iajs-877	34	78	%	%	NOUN
iajs-877	34	79	in	in	ADP
iajs-877	34	80	sudan	sudan	PROPN
iajs-877	34	81	,	,	PUNCT
iajs-877	34	82	6.5	6.5	NUM
iajs-877	34	83	%	%	NOUN
iajs-877	34	84	in	in	ADP
iajs-877	34	85	tunisia	tunisia	NOUN
iajs-877	34	86	,	,	PUNCT
iajs-877	34	87	2	2	NUM
iajs-877	34	88	%	%	NOUN
iajs-877	34	89	to	to	PART
iajs-877	34	90	5	5	NUM
iajs-877	34	91	%	%	NOUN
iajs-877	34	92	in	in	ADP
iajs-877	34	93	uae	uae	PROPN
iajs-877	34	94	and	and	CCONJ
iajs-877	34	95	12.7	12.7	NUM
iajs-877	34	96	%	%	NOUN
iajs-877	34	97	to	to	ADP
iajs-877	34	98	18.5	18.5	NUM
iajs-877	34	99	%	%	NOUN
iajs-877	34	100	in	in	ADP
iajs-877	34	101	the	the	DET
iajs-877	34	102	republic	republic	NOUN
iajs-877	34	103	of	of	ADP
iajs-877	34	104	yemen	yemen	PROPN
iajs-877	34	105	.	.	PUNCT
iajs-877	35	1	the	the	DET
iajs-877	35	2	studies	study	NOUN
iajs-877	35	3	conducted	conduct	VERB
iajs-877	35	4	in	in	ADP
iajs-877	35	5	the	the	DET
iajs-877	35	6	middle	middle	PROPN
iajs-877	35	7	east	east	PROPN
iajs-877	35	8	have	have	AUX
iajs-877	35	9	collectively	collectively	ADV
iajs-877	35	10	found	find	VERB
iajs-877	35	11	that	that	SCONJ
iajs-877	35	12	hbv	hbv	NOUN
iajs-877	35	13	infection	infection	NOUN
iajs-877	35	14	is	be	AUX
iajs-877	35	15	a	a	DET
iajs-877	35	16	serious	serious	ADJ
iajs-877	35	17	public	public	ADJ
iajs-877	35	18	health	health	NOUN
iajs-877	35	19	problem	problem	NOUN
iajs-877	35	20	in	in	ADP
iajs-877	35	21	the	the	DET
iajs-877	35	22	region	region	NOUN
iajs-877	35	23	.	.	PUNCT
iajs-877	36	1	[	[	X
iajs-877	36	2	7	7	X
iajs-877	36	3	]	]	X
iajs-877	36	4	hepatitis	hepatitis	NOUN
iajs-877	36	5	c	c	PROPN
iajs-877	36	6	infection	infection	NOUN
iajs-877	36	7	is	be	AUX
iajs-877	36	8	now	now	ADV
iajs-877	36	9	the	the	DET
iajs-877	36	10	most	most	ADV
iajs-877	36	11	common	common	ADJ
iajs-877	36	12	cause	cause	NOUN
iajs-877	36	13	of	of	ADP
iajs-877	36	14	end	end	NOUN
iajs-877	36	15	-	-	PUNCT
iajs-877	36	16	stage	stage	NOUN
iajs-877	36	17	liver	liver	NOUN
iajs-877	36	18	disease	disease	NOUN
iajs-877	36	19	in	in	ADP
iajs-877	36	20	many	many	ADJ
iajs-877	36	21	countries	country	NOUN
iajs-877	36	22	.	.	PUNCT
iajs-877	37	1	it	it	PRON
iajs-877	37	2	is	be	AUX
iajs-877	37	3	a	a	DET
iajs-877	37	4	blood	blood	NOUN
iajs-877	37	5	-	-	PUNCT
iajs-877	37	6	borne	bear	VERB
iajs-877	37	7	infection	infection	NOUN
iajs-877	37	8	that	that	PRON
iajs-877	37	9	was	be	AUX
iajs-877	37	10	a	a	DET
iajs-877	37	11	well	well	ADV
iajs-877	37	12	-	-	PUNCT
iajs-877	37	13	known	know	VERB
iajs-877	37	14	cause	cause	NOUN
iajs-877	37	15	of	of	ADP
iajs-877	37	16	post	post	ADJ
iajs-877	37	17	-	-	ADJ
iajs-877	37	18	transfusion	transfusion	ADJ
iajs-877	37	19	hepatitis	hepatitis	NOUN
iajs-877	37	20	after	after	ADP
iajs-877	37	21	introduction	introduction	NOUN
iajs-877	37	22	of	of	ADP
iajs-877	37	23	hepatitis	hepatitis	PROPN
iajs-877	37	24	b	b	PROPN
iajs-877	37	25	screening	screening	NOUN
iajs-877	37	26	in	in	ADP
iajs-877	37	27	blood	blood	NOUN
iajs-877	37	28	banking	banking	NOUN
iajs-877	37	29	and	and	CCONJ
iajs-877	37	30	before	before	ADP
iajs-877	37	31	implementation	implementation	NOUN
iajs-877	37	32	of	of	ADP
iajs-877	37	33	hepatitis	hepatitis	PROPN
iajs-877	37	34	c	c	NOUN
iajs-877	37	35	-	-	PUNCT
iajs-877	37	36	sensitive	sensitive	ADJ
iajs-877	37	37	screening	screen	VERB
iajs-877	37	38	laboratory	laboratory	NOUN
iajs-877	37	39	methods	method	NOUN
iajs-877	37	40	.	.	PUNCT
iajs-877	38	1	world	world	PROPN
iajs-877	38	2	health	health	PROPN
iajs-877	38	3	organization	organization	NOUN
iajs-877	38	4	(	(	PUNCT
iajs-877	38	5	who	who	PRON
iajs-877	38	6	)	)	PUNCT
iajs-877	38	7	estimations	estimation	NOUN
iajs-877	38	8	suggest	suggest	VERB
iajs-877	38	9	that	that	SCONJ
iajs-877	38	10	up	up	ADP
iajs-877	38	11	to	to	PART
iajs-877	38	12	3	3	NUM
iajs-877	38	13	%	%	NOUN
iajs-877	38	14	of	of	ADP
iajs-877	38	15	the	the	DET
iajs-877	38	16	world	world	NOUN
iajs-877	38	17	's	's	PART
iajs-877	38	18	population	population	NOUN
iajs-877	38	19	(	(	PUNCT
iajs-877	38	20	170	170	NUM
iajs-877	38	21	million	million	NUM
iajs-877	38	22	)	)	PUNCT
iajs-877	38	23	have	have	AUX
iajs-877	38	24	been	be	AUX
iajs-877	38	25	infected	infect	VERB
iajs-877	38	26	with	with	ADP
iajs-877	38	27	hcv	hcv	PROPN
iajs-877	38	28	[	[	X
iajs-877	38	29	8	8	NUM
iajs-877	38	30	]	]	PUNCT
iajs-877	38	31	.	.	PUNCT
iajs-877	39	1	regionally	regionally	ADV
iajs-877	39	2	,	,	PUNCT
iajs-877	39	3	the	the	DET
iajs-877	39	4	highest	high	ADJ
iajs-877	39	5	prevalence	prevalence	NOUN
iajs-877	39	6	of	of	ADP
iajs-877	39	7	hcv	hcv	PROPN
iajs-877	39	8	infection	infection	NOUN
iajs-877	39	9	occurs	occur	VERB
iajs-877	39	10	in	in	ADP
iajs-877	39	11	egypt	egypt	PROPN
iajs-877	39	12	,	,	PUNCT
iajs-877	39	13	where	where	SCONJ
iajs-877	39	14	the	the	DET
iajs-877	39	15	prevalence	prevalence	NOUN
iajs-877	39	16	of	of	ADP
iajs-877	39	17	infection	infection	NOUN
iajs-877	39	18	increases	increase	VERB
iajs-877	39	19	steadily	steadily	ADV
iajs-877	39	20	with	with	ADP
iajs-877	39	21	age	age	NOUN
iajs-877	39	22	,	,	PUNCT
iajs-877	39	23	and	and	CCONJ
iajs-877	39	24	high	high	ADJ
iajs-877	39	25	rates	rate	NOUN
iajs-877	39	26	of	of	ADP
iajs-877	39	27	infection	infection	NOUN
iajs-877	39	28	are	be	AUX
iajs-877	39	29	observed	observe	VERB
iajs-877	39	30	among	among	ADP
iajs-877	39	31	persons	person	NOUN
iajs-877	39	32	in	in	ADP
iajs-877	39	33	all	all	DET
iajs-877	39	34	age	age	NOUN
iajs-877	39	35	groups	group	NOUN
iajs-877	40	1	[	[	X
iajs-877	40	2	9	9	NUM
iajs-877	40	3	]	]	PUNCT
iajs-877	40	4	.	.	PUNCT
iajs-877	41	1	materials	material	NOUN
iajs-877	41	2	and	and	CCONJ
iajs-877	41	3	methods	method	NOUN
iajs-877	41	4	patients	patient	NOUN
iajs-877	41	5	population	population	NOUN
iajs-877	41	6	we	we	PRON
iajs-877	41	7	studied	study	VERB
iajs-877	41	8	one	one	NUM
iajs-877	41	9	hundred	hundred	NUM
iajs-877	41	10	patients	patient	NOUN
iajs-877	41	11	with	with	ADP
iajs-877	41	12	chronic	chronic	ADJ
iajs-877	41	13	viral	viral	ADJ
iajs-877	41	14	hepatitis	hepatitis	NOUN
iajs-877	41	15	,	,	PUNCT
iajs-877	41	16	50	50	NUM
iajs-877	41	17	of	of	ADP
iajs-877	41	18	them	they	PRON
iajs-877	41	19	(	(	PUNCT
iajs-877	41	20	36	36	NUM
iajs-877	41	21	males	male	NOUN
iajs-877	41	22	and	and	CCONJ
iajs-877	41	23	14	14	NUM
iajs-877	41	24	females	female	NOUN
iajs-877	41	25	)	)	PUNCT
iajs-877	41	26	with	with	ADP
iajs-877	41	27	chronic	chronic	ADJ
iajs-877	41	28	hbv	hbv	NOUN
iajs-877	41	29	infection	infection	NOUN
iajs-877	41	30	and	and	CCONJ
iajs-877	41	31	50	50	NUM
iajs-877	41	32	patients	patient	NOUN
iajs-877	41	33	(	(	PUNCT
iajs-877	41	34	32	32	NUM
iajs-877	41	35	males	male	NOUN
iajs-877	41	36	and	and	CCONJ
iajs-877	41	37	18	18	NUM
iajs-877	41	38	females	female	NOUN
iajs-877	41	39	)	)	PUNCT
iajs-877	41	40	with	with	ADP
iajs-877	41	41	chronic	chronic	ADJ
iajs-877	41	42	hcv	hcv	NOUN
iajs-877	41	43	infection	infection	NOUN
iajs-877	41	44	,	,	PUNCT
iajs-877	41	45	who	who	PRON
iajs-877	41	46	were	be	AUX
iajs-877	41	47	in	in	ADP
iajs-877	41	48	regular	regular	ADJ
iajs-877	41	49	follow	follow	NOUN
iajs-877	41	50	-	-	PUNCT
iajs-877	41	51	up	up	NOUN
iajs-877	41	52	at	at	ADP
iajs-877	41	53	the	the	DET
iajs-877	41	54	gastroenterology	gastroenterology	NOUN
iajs-877	41	55	and	and	CCONJ
iajs-877	41	56	hepatology	hepatology	NOUN
iajs-877	41	57	center	center	PROPN
iajs-877	41	58	/	/	SYM
iajs-877	41	59	baghdad	baghdad	PROPN
iajs-877	41	60	.	.	PUNCT
iajs-877	42	1	twenty	twenty	NUM
iajs-877	42	2	unrelated	unrelated	ADJ
iajs-877	42	3	apparently	apparently	ADV
iajs-877	42	4	healthy	healthy	ADJ
iajs-877	42	5	,	,	PUNCT
iajs-877	42	6	age	age	NOUN
iajs-877	42	7	and	and	CCONJ
iajs-877	42	8	gender	gender	NOUN
iajs-877	42	9	matched	match	VERB
iajs-877	42	10	subjects	subject	NOUN
iajs-877	42	11	were	be	AUX
iajs-877	42	12	included	include	VERB
iajs-877	42	13	as	as	ADP
iajs-877	42	14	a	a	DET
iajs-877	42	15	control	control	NOUN
iajs-877	42	16	group	group	NOUN
iajs-877	42	17	.	.	PUNCT
iajs-877	43	1	chronic	chronic	ADJ
iajs-877	43	2	hbv	hbv	NOUN
iajs-877	43	3	infection	infection	NOUN
iajs-877	43	4	was	be	AUX
iajs-877	43	5	defined	define	VERB
iajs-877	43	6	by	by	ADP
iajs-877	43	7	the	the	DET
iajs-877	43	8	presence	presence	NOUN
iajs-877	43	9	of	of	ADP
iajs-877	43	10	hepatitis	hepatitis	PROPN
iajs-877	43	11	b	b	PROPN
iajs-877	43	12	surface	surface	NOUN
iajs-877	43	13	antigen	antigen	NOUN
iajs-877	43	14	(	(	PUNCT
iajs-877	43	15	hbsag	hbsag	NOUN
iajs-877	43	16	)	)	PUNCT
iajs-877	43	17	in	in	ADP
iajs-877	43	18	serum	serum	NOUN
iajs-877	43	19	for	for	ADP
iajs-877	43	20	more	more	ADJ
iajs-877	43	21	than	than	ADP
iajs-877	43	22	6	6	NUM
iajs-877	43	23	months	month	NOUN
iajs-877	43	24	,	,	PUNCT
iajs-877	43	25	while	while	SCONJ
iajs-877	43	26	chronic	chronic	ADJ
iajs-877	43	27	hcv	hcv	NOUN
iajs-877	43	28	infection	infection	NOUN
iajs-877	43	29	was	be	AUX
iajs-877	43	30	defined	define	VERB
iajs-877	43	31	by	by	ADP
iajs-877	43	32	the	the	DET
iajs-877	43	33	presence	presence	NOUN
iajs-877	43	34	of	of	ADP
iajs-877	43	35	hcv	hcv	PROPN
iajs-877	43	36	rna	rna	PROPN
iajs-877	43	37	in	in	ADP
iajs-877	43	38	serum	serum	NOUN
iajs-877	43	39	for	for	ADP
iajs-877	43	40	more	more	ADJ
iajs-877	43	41	than	than	ADP
iajs-877	43	42	6	6	NUM
iajs-877	43	43	months	month	NOUN
iajs-877	43	44	which	which	PRON
iajs-877	43	45	was	be	AUX
iajs-877	43	46	done	do	VERB
iajs-877	43	47	by	by	ADP
iajs-877	43	48	using	use	VERB
iajs-877	43	49	commercially	commercially	ADV
iajs-877	43	50	available	available	ADJ
iajs-877	43	51	enzyme	enzyme	NOUN
iajs-877	43	52	linked	link	VERB
iajs-877	43	53	immunosorbent	immunosorbent	ADJ
iajs-877	43	54	assay	assay	PROPN
iajs-877	43	55	(	(	PUNCT
iajs-877	43	56	elisa	elisa	NOUN
iajs-877	43	57	)	)	PUNCT
iajs-877	43	58	and	and	CCONJ
iajs-877	43	59	performed	perform	VERB
iajs-877	43	60	according	accord	VERB
iajs-877	43	61	to	to	ADP
iajs-877	43	62	the	the	DET
iajs-877	43	63	manufactures	manufacture	NOUN
iajs-877	43	64	instructions	instruction	NOUN
iajs-877	43	65	.	.	PUNCT
iajs-877	44	1	methods	method	NOUN
iajs-877	44	2	venous	venous	ADJ
iajs-877	44	3	blood	blood	NOUN
iajs-877	44	4	samples	sample	NOUN
iajs-877	44	5	were	be	AUX
iajs-877	44	6	collected	collect	VERB
iajs-877	44	7	from	from	ADP
iajs-877	44	8	all	all	DET
iajs-877	44	9	patients	patient	NOUN
iajs-877	44	10	,	,	PUNCT
iajs-877	44	11	hematological	hematological	ADJ
iajs-877	44	12	tests	test	NOUN
iajs-877	44	13	were	be	AUX
iajs-877	44	14	done	do	VERB
iajs-877	44	15	,	,	PUNCT
iajs-877	44	16	including	include	VERB
iajs-877	44	17	total	total	ADJ
iajs-877	44	18	white	white	ADJ
iajs-877	44	19	blood	blood	NOUN
iajs-877	44	20	cell	cell	NOUN
iajs-877	44	21	count	count	NOUN
iajs-877	44	22	and	and	CCONJ
iajs-877	44	23	estimation	estimation	NOUN
iajs-877	44	24	of	of	ADP
iajs-877	44	25	hemoglobulin	hemoglobulin	PROPN
iajs-877	44	26	concentration	concentration	NOUN
iajs-877	44	27	.	.	PUNCT
iajs-877	45	1	liver	liver	NOUN
iajs-877	45	2	function	function	NOUN
iajs-877	45	3	tests	test	NOUN
iajs-877	45	4	were	be	AUX
iajs-877	45	5	performed	perform	VERB
iajs-877	45	6	manually	manually	ADV
iajs-877	45	7	by	by	ADP
iajs-877	45	8	using	use	VERB
iajs-877	45	9	assays	assay	NOUN
iajs-877	45	10	which	which	PRON
iajs-877	45	11	were	be	AUX
iajs-877	45	12	done	do	VERB
iajs-877	45	13	according	accord	VERB
iajs-877	45	14	to	to	ADP
iajs-877	45	15	the	the	DET
iajs-877	45	16	manufacturers	manufacturer	NOUN
iajs-877	45	17	instructions	instruction	NOUN
iajs-877	45	18	using	use	VERB
iajs-877	45	19	standard	standard	ADJ
iajs-877	45	20	routine	routine	ADJ
iajs-877	45	21	spectrophotometric	spectrophotometric	ADJ
iajs-877	45	22	methodology	methodology	NOUN
iajs-877	45	23	[	[	X
iajs-877	45	24	10	10	NUM
iajs-877	45	25	]	]	PUNCT
iajs-877	45	26	in	in	ADP
iajs-877	45	27	all	all	DET
iajs-877	45	28	patients	patient	NOUN
iajs-877	45	29	which	which	PRON
iajs-877	45	30	included	include	VERB
iajs-877	45	31	the	the	DET
iajs-877	45	32	following	follow	VERB
iajs-877	45	33	kits	kit	NOUN
iajs-877	45	34	;	;	PUNCT
iajs-877	45	35	1	1	NUM
iajs-877	45	36	-	-	PUNCT
iajs-877	45	37	total	total	NOUN
iajs-877	45	38	serum	serum	NOUN
iajs-877	45	39	bilirubine	bilirubine	NOUN
iajs-877	45	40	(	(	PUNCT
iajs-877	45	41	tsb)-randox	tsb)-randox	NOUN
iajs-877	45	42	company	company	NOUN
iajs-877	45	43	;	;	PUNCT
iajs-877	45	44	spectrophotometric	spectrophotometric	ADJ
iajs-877	45	45	determination	determination	NOUN
iajs-877	45	46	(	(	PUNCT
iajs-877	45	47	winstel	winstel	NOUN
iajs-877	45	48	and	and	CCONJ
iajs-877	45	49	cehelyk	cehelyk	NOUN
iajs-877	45	50	method	method	NOUN
iajs-877	45	51	)	)	PUNCT
iajs-877	45	52	2alanine	2alanine	NUM
iajs-877	45	53	aminotransferase	aminotransferase	NOUN
iajs-877	45	54	(	(	PUNCT
iajs-877	45	55	alt)-randox	alt)-randox	ADJ
iajs-877	45	56	company	company	NOUN
iajs-877	45	57	;	;	PUNCT
iajs-877	45	58	sphectrophotometric	sphectrophotometric	ADJ
iajs-877	45	59	determination	determination	NOUN
iajs-877	45	60	(	(	PUNCT
iajs-877	45	61	reitman	reitman	NOUN
iajs-877	45	62	and	and	CCONJ
iajs-877	45	63	frankel	frankel	NOUN
iajs-877	45	64	method	method	NOUN
iajs-877	45	65	)	)	PUNCT
iajs-877	45	66	3aspartate	3aspartate	NUM
iajs-877	45	67	aminotransferase	aminotransferase	NOUN
iajs-877	45	68	(	(	PUNCT
iajs-877	45	69	ast)-randox	ast)-randox	PROPN
iajs-877	45	70	company	company	NOUN
iajs-877	45	71	;	;	PUNCT
iajs-877	45	72	ibn	ibn	PROPN
iajs-877	45	73	alhaitham	alhaitham	NOUN
iajs-877	45	74	j.	j.	PROPN
iajs-877	46	1	fo	fo	ADP
iajs-877	46	2	r	r	NOUN
iajs-877	46	3	pure	pure	ADJ
iajs-877	46	4	&	&	CCONJ
iajs-877	46	5	appl	appl	PROPN
iajs-877	46	6	.	.	PUNCT
iajs-877	47	1	sci	sci	PROPN
iajs-877	47	2	.	.	PROPN
iajs-877	48	1	vo	vo	INTJ
iajs-877	48	2	l.24	l.24	PROPN
iajs-877	48	3	(	(	PUNCT
iajs-877	48	4	1	1	NUM
iajs-877	48	5	)	)	PUNCT
iajs-877	48	6	2011	2011	NUM
iajs-877	48	7	sphectrophotometric	sphectrophotometric	ADJ
iajs-877	48	8	determination	determination	NOUN
iajs-877	48	9	(	(	PUNCT
iajs-877	48	10	reitman	reitman	NOUN
iajs-877	48	11	and	and	CCONJ
iajs-877	48	12	frankel	frankel	NOUN
iajs-877	48	13	method	method	NOUN
iajs-877	48	14	)	)	PUNCT
iajs-877	48	15	4	4	NUM
iajs-877	48	16	-	-	PUNCT
iajs-877	48	17	alkaline	alkaline	NOUN
iajs-877	48	18	phosphatase	phosphatase	NOUN
iajs-877	48	19	(	(	PUNCT
iajs-877	48	20	alp)-biomerieux	alp)-biomerieux	NOUN
iajs-877	48	21	-	-	NOUN
iajs-877	48	22	company	company	NOUN
iajs-877	48	23	;	;	PUNCT
iajs-877	48	24	spectrophotometric	spectrophotometric	ADJ
iajs-877	48	25	determination	determination	NOUN
iajs-877	48	26	of	of	ADP
iajs-877	48	27	alkaline	alkaline	ADJ
iajs-877	48	28	phosphatase	phosphatase	NOUN
iajs-877	48	29	activity	activity	NOUN
iajs-877	48	30	statistical	statistical	ADJ
iajs-877	48	31	analysis	analysis	NOUN
iajs-877	48	32	the	the	DET
iajs-877	48	33	test	test	NOUN
iajs-877	48	34	results	result	NOUN
iajs-877	48	35	are	be	AUX
iajs-877	48	36	expressed	express	VERB
iajs-877	48	37	as	as	ADP
iajs-877	48	38	the	the	DET
iajs-877	48	39	mean	mean	PROPN
iajs-877	48	40	±	±	NUM
iajs-877	48	41	standard	standard	ADJ
iajs-877	48	42	deviation	deviation	NOUN
iajs-877	48	43	(	(	PUNCT
iajs-877	48	44	sd	sd	NOUN
iajs-877	48	45	)	)	PUNCT
iajs-877	48	46	.	.	PUNCT
iajs-877	49	1	data	datum	NOUN
iajs-877	49	2	collected	collect	VERB
iajs-877	49	3	were	be	AUX
iajs-877	49	4	subjected	subject	VERB
iajs-877	49	5	to	to	ADP
iajs-877	49	6	analysis	analysis	NOUN
iajs-877	49	7	of	of	ADP
iajs-877	49	8	variance	variance	NOUN
iajs-877	49	9	(	(	PUNCT
iajs-877	49	10	anova	anova	PROPN
iajs-877	49	11	)	)	PUNCT
iajs-877	49	12	,	,	PUNCT
iajs-877	49	13	while	while	SCONJ
iajs-877	49	14	the	the	DET
iajs-877	49	15	means	mean	NOUN
iajs-877	49	16	were	be	AUX
iajs-877	49	17	separated	separate	VERB
iajs-877	49	18	with	with	ADP
iajs-877	49	19	lsd	lsd	NOUN
iajs-877	49	20	test	test	NOUN
iajs-877	49	21	using	use	VERB
iajs-877	49	22	statistical	statistical	ADJ
iajs-877	49	23	programme	programme	NOUN
iajs-877	49	24	for	for	ADP
iajs-877	49	25	windows	window	NOUN
iajs-877	49	26	,	,	PUNCT
iajs-877	49	27	p	p	NOUN
iajs-877	49	28	value	value	NOUN
iajs-877	49	29	of	of	ADP
iajs-877	49	30	≤	≤	NUM
iajs-877	49	31	0.05	0.05	NUM
iajs-877	49	32	was	be	AUX
iajs-877	49	33	considered	consider	VERB
iajs-877	49	34	significant	significant	ADJ
iajs-877	49	35	[	[	X
iajs-877	49	36	11	11	NUM
iajs-877	49	37	]	]	PUNCT
iajs-877	49	38	.	.	PUNCT
iajs-877	50	1	results	result	NOUN
iajs-877	50	2	in	in	ADP
iajs-877	50	3	our	our	PRON
iajs-877	50	4	study	study	NOUN
iajs-877	50	5	the	the	DET
iajs-877	50	6	patients	patient	NOUN
iajs-877	50	7	population	population	NOUN
iajs-877	50	8	consisted	consist	VERB
iajs-877	50	9	of	of	ADP
iajs-877	50	10	68	68	NUM
iajs-877	50	11	males	male	NOUN
iajs-877	50	12	(	(	PUNCT
iajs-877	50	13	68	68	NUM
iajs-877	50	14	%	%	NOUN
iajs-877	50	15	)	)	PUNCT
iajs-877	50	16	and	and	CCONJ
iajs-877	50	17	32	32	NUM
iajs-877	50	18	females	female	NOUN
iajs-877	50	19	(	(	PUNCT
iajs-877	50	20	32	32	NUM
iajs-877	50	21	%	%	NOUN
iajs-877	50	22	)	)	PUNCT
iajs-877	50	23	.	.	PUNCT
iajs-877	51	1	mean	mean	VERB
iajs-877	51	2	age	age	NOUN
iajs-877	51	3	of	of	ADP
iajs-877	51	4	our	our	PRON
iajs-877	51	5	patients	patient	NOUN
iajs-877	51	6	was	be	AUX
iajs-877	51	7	38.4±14.9	38.4±14.9	NUM
iajs-877	51	8	years	year	NOUN
iajs-877	51	9	.	.	PUNCT
iajs-877	52	1	mean	mean	VERB
iajs-877	52	2	ages	age	NOUN
iajs-877	52	3	for	for	ADP
iajs-877	52	4	chronic	chronic	ADJ
iajs-877	52	5	hepatitis	hepatitis	PROPN
iajs-877	52	6	b	b	PROPN
iajs-877	52	7	and	and	CCONJ
iajs-877	52	8	hepatitis	hepatitis	PROPN
iajs-877	52	9	c	c	PROPN
iajs-877	52	10	patients	patient	NOUN
iajs-877	52	11	were	be	AUX
iajs-877	52	12	36.9	36.9	NUM
iajs-877	52	13	±	±	NUM
iajs-877	52	14	15.8	15.8	NUM
iajs-877	52	15	years	year	NOUN
iajs-877	52	16	(	(	PUNCT
iajs-877	52	17	11	11	NUM
iajs-877	52	18	–	–	PUNCT
iajs-877	52	19	65years	65years	NUM
iajs-877	52	20	)	)	PUNCT
iajs-877	52	21	and	and	CCONJ
iajs-877	52	22	39.9	39.9	NUM
iajs-877	52	23	±14.2	±14.2	NOUN
iajs-877	52	24	years	year	NOUN
iajs-877	52	25	(	(	PUNCT
iajs-877	52	26	7	7	NUM
iajs-877	52	27	-	-	SYM
iajs-877	52	28	61	61	NUM
iajs-877	52	29	years	year	NOUN
iajs-877	52	30	)	)	PUNCT
iajs-877	52	31	respectively	respectively	ADV
iajs-877	52	32	,	,	PUNCT
iajs-877	52	33	table	table	NOUN
iajs-877	52	34	(	(	PUNCT
iajs-877	52	35	1	1	NUM
iajs-877	52	36	)	)	PUNCT
iajs-877	52	37	.	.	PUNCT
iajs-877	53	1	table	table	NOUN
iajs-877	53	2	(	(	PUNCT
iajs-877	53	3	2	2	X
iajs-877	53	4	)	)	PUNCT
iajs-877	53	5	compares	compare	VERB
iajs-877	53	6	the	the	DET
iajs-877	53	7	levels	level	NOUN
iajs-877	53	8	of	of	ADP
iajs-877	53	9	liver	liver	NOUN
iajs-877	53	10	function	function	NOUN
iajs-877	53	11	tests	test	NOUN
iajs-877	53	12	between	between	ADP
iajs-877	53	13	hbv	hbv	NOUN
iajs-877	53	14	and	and	CCONJ
iajs-877	53	15	hcv	hcv	NOUN
iajs-877	53	16	patients	patient	NOUN
iajs-877	53	17	,	,	PUNCT
iajs-877	53	18	which	which	PRON
iajs-877	53	19	shows	show	VERB
iajs-877	53	20	that	that	SCONJ
iajs-877	53	21	the	the	DET
iajs-877	53	22	mean	mean	NOUN
iajs-877	53	23	of	of	ADP
iajs-877	53	24	total	total	ADJ
iajs-877	53	25	serum	serum	NOUN
iajs-877	53	26	bilirubine	bilirubine	NOUN
iajs-877	53	27	level	level	NOUN
iajs-877	53	28	was	be	AUX
iajs-877	53	29	4.1	4.1	NUM
iajs-877	53	30	±	±	NUM
iajs-877	53	31	3.1	3.1	NUM
iajs-877	53	32	and	and	CCONJ
iajs-877	53	33	4.2	4.2	NUM
iajs-877	53	34	±	±	NUM
iajs-877	53	35	3	3	NUM
iajs-877	53	36	mg	mg	PROPN
iajs-877	53	37	/	/	SYM
iajs-877	53	38	dl	dl	PROPN
iajs-877	53	39	in	in	ADP
iajs-877	53	40	hbv	hbv	NOUN
iajs-877	53	41	and	and	CCONJ
iajs-877	53	42	hcv	hcv	VERB
iajs-877	53	43	patients	patient	NOUN
iajs-877	53	44	respectively	respectively	ADV
iajs-877	53	45	.	.	PUNCT
iajs-877	54	1	on	on	ADP
iajs-877	54	2	the	the	DET
iajs-877	54	3	other	other	ADJ
iajs-877	54	4	hand	hand	NOUN
iajs-877	54	5	,	,	PUNCT
iajs-877	54	6	ast	ast	NOUN
iajs-877	54	7	level	level	NOUN
iajs-877	54	8	in	in	ADP
iajs-877	54	9	hbv	hbv	NOUN
iajs-877	54	10	and	and	CCONJ
iajs-877	54	11	hcv	hcv	NOUN
iajs-877	54	12	patients	patient	NOUN
iajs-877	54	13	were	be	AUX
iajs-877	54	14	37.8±	37.8±	NUM
iajs-877	54	15	10.4	10.4	NUM
iajs-877	54	16	iu	iu	ADP
iajs-877	54	17	/	/	SYM
iajs-877	54	18	l	l	NOUN
iajs-877	54	19	and	and	CCONJ
iajs-877	54	20	41.6±	41.6±	NOUN
iajs-877	54	21	14.2	14.2	NUM
iajs-877	54	22	iu	iu	NOUN
iajs-877	54	23	/	/	SYM
iajs-877	54	24	l	l	NOUN
iajs-877	54	25	respectively	respectively	ADV
iajs-877	54	26	.	.	PUNCT
iajs-877	55	1	the	the	DET
iajs-877	55	2	same	same	ADJ
iajs-877	55	3	table	table	NOUN
iajs-877	55	4	also	also	ADV
iajs-877	55	5	demonstrates	demonstrate	VERB
iajs-877	55	6	that	that	SCONJ
iajs-877	55	7	the	the	DET
iajs-877	55	8	level	level	NOUN
iajs-877	55	9	of	of	ADP
iajs-877	55	10	alt	alt	NOUN
iajs-877	55	11	was	be	AUX
iajs-877	55	12	55±40.8	55±40.8	PROPN
iajs-877	55	13	and	and	CCONJ
iajs-877	55	14	60.4±29.3	60.4±29.3	NUM
iajs-877	55	15	iu	iu	ADP
iajs-877	55	16	/	/	SYM
iajs-877	55	17	l	l	NOUN
iajs-877	55	18	in	in	ADP
iajs-877	55	19	hbv	hbv	NOUN
iajs-877	55	20	and	and	CCONJ
iajs-877	55	21	hcv	hcv	NOUN
iajs-877	55	22	cases	case	NOUN
iajs-877	55	23	respectively	respectively	ADV
iajs-877	55	24	,	,	PUNCT
iajs-877	55	25	meanwhile	meanwhile	ADV
iajs-877	55	26	alp	alp	PROPN
iajs-877	55	27	level	level	NOUN
iajs-877	55	28	was	be	AUX
iajs-877	55	29	82.1±46.5	82.1±46.5	NUM
iajs-877	55	30	iu	iu	ADP
iajs-877	55	31	/	/	SYM
iajs-877	55	32	l	l	NOUN
iajs-877	55	33	in	in	ADP
iajs-877	55	34	hbv	hbv	NOUN
iajs-877	55	35	patients	patient	NOUN
iajs-877	55	36	and	and	CCONJ
iajs-877	55	37	86.3±	86.3±	NUM
iajs-877	55	38	44.7	44.7	NUM
iajs-877	55	39	iu	iu	NOUN
iajs-877	55	40	/	/	SYM
iajs-877	55	41	l	l	NOUN
iajs-877	55	42	in	in	ADP
iajs-877	55	43	hcv	hcv	NOUN
iajs-877	55	44	patients	patient	NOUN
iajs-877	55	45	.	.	PUNCT
iajs-877	56	1	statistical	statistical	ADJ
iajs-877	56	2	analysis	analysis	NOUN
iajs-877	56	3	showed	show	VERB
iajs-877	56	4	that	that	SCONJ
iajs-877	56	5	there	there	PRON
iajs-877	56	6	was	be	VERB
iajs-877	56	7	no	no	DET
iajs-877	56	8	significant	significant	ADJ
iajs-877	56	9	difference	difference	NOUN
iajs-877	56	10	between	between	ADP
iajs-877	56	11	hbv	hbv	NOUN
iajs-877	56	12	and	and	CCONJ
iajs-877	56	13	hcv	hcv	NOUN
iajs-877	56	14	patients	patient	NOUN
iajs-877	56	15	concerning	concern	VERB
iajs-877	56	16	liver	liver	NOUN
iajs-877	56	17	function	function	NOUN
iajs-877	56	18	tests	test	NOUN
iajs-877	56	19	.	.	PUNCT
iajs-877	57	1	however	however	ADV
iajs-877	57	2	both	both	DET
iajs-877	57	3	hbv	hbv	NOUN
iajs-877	57	4	and	and	CCONJ
iajs-877	57	5	hcv	hcv	PROPN
iajs-877	57	6	showed	show	VERB
iajs-877	57	7	a	a	DET
iajs-877	57	8	significant	significant	ADJ
iajs-877	57	9	difference	difference	NOUN
iajs-877	57	10	in	in	ADP
iajs-877	57	11	liver	liver	NOUN
iajs-877	57	12	function	function	NOUN
iajs-877	57	13	tests	test	NOUN
iajs-877	57	14	when	when	SCONJ
iajs-877	57	15	compared	compare	VERB
iajs-877	57	16	with	with	ADP
iajs-877	57	17	the	the	DET
iajs-877	57	18	control	control	NOUN
iajs-877	57	19	group	group	NOUN
iajs-877	57	20	.	.	PUNCT
iajs-877	58	1	the	the	DET
iajs-877	58	2	data	datum	NOUN
iajs-877	58	3	demonstrated	demonstrate	VERB
iajs-877	58	4	by	by	ADP
iajs-877	58	5	table	table	NOUN
iajs-877	58	6	(	(	PUNCT
iajs-877	58	7	3	3	NUM
iajs-877	58	8	)	)	PUNCT
iajs-877	58	9	and	and	CCONJ
iajs-877	58	10	figure	figure	NOUN
iajs-877	58	11	(	(	PUNCT
iajs-877	58	12	1	1	X
iajs-877	58	13	)	)	PUNCT
iajs-877	58	14	show	show	VERB
iajs-877	58	15	a	a	DET
iajs-877	58	16	significant	significant	ADJ
iajs-877	58	17	difference	difference	NOUN
iajs-877	58	18	between	between	ADP
iajs-877	58	19	hbv	hbv	NOUN
iajs-877	58	20	and	and	CCONJ
iajs-877	58	21	hcv	hcv	NOUN
iajs-877	58	22	patients	patient	NOUN
iajs-877	58	23	concerning	concern	VERB
iajs-877	58	24	total	total	ADJ
iajs-877	58	25	wbc	wbc	PROPN
iajs-877	58	26	count	count	NOUN
iajs-877	58	27	which	which	PRON
iajs-877	58	28	was	be	AUX
iajs-877	58	29	6224	6224	NUM
iajs-877	58	30	±	±	NUM
iajs-877	58	31	1749.1	1749.1	NUM
iajs-877	58	32	and	and	CCONJ
iajs-877	58	33	4296±	4296±	NUM
iajs-877	58	34	1050.9	1050.9	NUM
iajs-877	58	35	cell/	cell/	NUM
iajs-877	58	36	mm3	mm3	NOUN
iajs-877	58	37	respectively	respectively	ADV
iajs-877	58	38	.	.	PUNCT
iajs-877	59	1	hemoglobulin	hemoglobulin	PROPN
iajs-877	59	2	concentration	concentration	NOUN
iajs-877	59	3	was	be	AUX
iajs-877	59	4	13.4	13.4	NUM
iajs-877	59	5	±	±	NUM
iajs-877	59	6	1.3	1.3	NUM
iajs-877	59	7	g	g	NOUN
iajs-877	59	8	/	/	SYM
iajs-877	59	9	dl	dl	PROPN
iajs-877	59	10	in	in	ADP
iajs-877	59	11	hbv	hbv	NOUN
iajs-877	59	12	patients	patient	NOUN
iajs-877	59	13	and	and	CCONJ
iajs-877	59	14	10.9	10.9	NUM
iajs-877	59	15	±	±	NUM
iajs-877	59	16	2.2	2.2	NUM
iajs-877	59	17	g	g	NOUN
iajs-877	59	18	/	/	SYM
iajs-877	59	19	dl	dl	PROPN
iajs-877	59	20	in	in	ADP
iajs-877	59	21	hcv	hcv	NOUN
iajs-877	59	22	patients	patient	NOUN
iajs-877	59	23	which	which	PRON
iajs-877	59	24	was	be	AUX
iajs-877	59	25	significant	significant	ADJ
iajs-877	59	26	as	as	SCONJ
iajs-877	59	27	illustrated	illustrate	VERB
iajs-877	59	28	by	by	ADP
iajs-877	59	29	table	table	NOUN
iajs-877	59	30	(	(	PUNCT
iajs-877	59	31	3	3	NUM
iajs-877	59	32	)	)	PUNCT
iajs-877	59	33	and	and	CCONJ
iajs-877	59	34	figure	figure	NOUN
iajs-877	59	35	(	(	PUNCT
iajs-877	59	36	2	2	NUM
iajs-877	59	37	)	)	PUNCT
iajs-877	59	38	.	.	PUNCT
iajs-877	60	1	however	however	ADV
iajs-877	60	2	hbv	hbv	NOUN
iajs-877	60	3	patients	patient	NOUN
iajs-877	60	4	showed	show	VERB
iajs-877	60	5	no	no	DET
iajs-877	60	6	significant	significant	ADJ
iajs-877	60	7	difference	difference	NOUN
iajs-877	60	8	when	when	SCONJ
iajs-877	60	9	compared	compare	VERB
iajs-877	60	10	with	with	ADP
iajs-877	60	11	control	control	NOUN
iajs-877	60	12	group	group	NOUN
iajs-877	60	13	regarding	regard	VERB
iajs-877	60	14	total	total	ADJ
iajs-877	60	15	white	white	ADJ
iajs-877	60	16	blood	blood	NOUN
iajs-877	60	17	cell	cell	NOUN
iajs-877	60	18	count	count	NOUN
iajs-877	60	19	(	(	PUNCT
iajs-877	60	20	7599±980	7599±980	NOUN
iajs-877	60	21	cell/	cell/	NUM
iajs-877	60	22	mm3	mm3	NOUN
iajs-877	60	23	)	)	PUNCT
iajs-877	60	24	and	and	CCONJ
iajs-877	60	25	hemoglobine	hemoglobine	NOUN
iajs-877	60	26	concentration	concentration	NOUN
iajs-877	60	27	(	(	PUNCT
iajs-877	60	28	13.8±1.9	13.8±1.9	NUM
iajs-877	60	29	g	g	NOUN
iajs-877	60	30	/	/	SYM
iajs-877	60	31	dl	dl	PROPN
iajs-877	60	32	)	)	PUNCT
iajs-877	60	33	.	.	PUNCT
iajs-877	61	1	discussion	discussion	NOUN
iajs-877	61	2	viral	viral	ADJ
iajs-877	61	3	hepatitis	hepatitis	NOUN
iajs-877	61	4	is	be	AUX
iajs-877	61	5	an	an	DET
iajs-877	61	6	important	important	ADJ
iajs-877	61	7	cause	cause	NOUN
iajs-877	61	8	of	of	ADP
iajs-877	61	9	chronic	chronic	ADJ
iajs-877	61	10	hepatitis	hepatitis	NOUN
iajs-877	61	11	.	.	PUNCT
iajs-877	62	1	based	base	VERB
iajs-877	62	2	on	on	ADP
iajs-877	62	3	the	the	DET
iajs-877	62	4	data	datum	NOUN
iajs-877	62	5	obtained	obtain	VERB
iajs-877	62	6	in	in	ADP
iajs-877	62	7	this	this	DET
iajs-877	62	8	study	study	NOUN
iajs-877	62	9	,	,	PUNCT
iajs-877	62	10	chronic	chronic	ADJ
iajs-877	62	11	viral	viral	ADJ
iajs-877	62	12	hepatitis	hepatitis	NOUN
iajs-877	62	13	was	be	AUX
iajs-877	62	14	more	more	ADV
iajs-877	62	15	prevalent	prevalent	ADJ
iajs-877	62	16	among	among	ADP
iajs-877	62	17	males	male	NOUN
iajs-877	62	18	than	than	ADP
iajs-877	62	19	females	female	NOUN
iajs-877	62	20	.	.	PUNCT
iajs-877	63	1	these	these	DET
iajs-877	63	2	findings	finding	NOUN
iajs-877	63	3	were	be	AUX
iajs-877	63	4	similar	similar	ADJ
iajs-877	63	5	to	to	ADP
iajs-877	63	6	those	those	PRON
iajs-877	63	7	obtained	obtain	VERB
iajs-877	63	8	in	in	ADP
iajs-877	63	9	another	another	DET
iajs-877	63	10	study	study	NOUN
iajs-877	63	11	which	which	PRON
iajs-877	63	12	reported	report	VERB
iajs-877	63	13	that	that	SCONJ
iajs-877	63	14	the	the	DET
iajs-877	63	15	male	male	NOUN
iajs-877	63	16	:	:	PUNCT
iajs-877	63	17	female	female	ADJ
iajs-877	63	18	ratio	ratio	NOUN
iajs-877	63	19	was	be	AUX
iajs-877	63	20	2:1	2:1	NUM
iajs-877	63	21	in	in	ADP
iajs-877	63	22	iraq	iraq	PROPN
iajs-877	64	1	[	[	X
iajs-877	64	2	12	12	NUM
iajs-877	64	3	]	]	PUNCT
iajs-877	64	4	.	.	PUNCT
iajs-877	65	1	on	on	ADP
iajs-877	65	2	the	the	DET
iajs-877	65	3	other	other	ADJ
iajs-877	65	4	hand	hand	NOUN
iajs-877	65	5	the	the	DET
iajs-877	65	6	current	current	ADJ
iajs-877	65	7	findings	finding	NOUN
iajs-877	65	8	disagree	disagree	VERB
iajs-877	65	9	with	with	ADP
iajs-877	65	10	the	the	DET
iajs-877	65	11	findings	finding	NOUN
iajs-877	65	12	of	of	ADP
iajs-877	65	13	another	another	DET
iajs-877	65	14	study	study	NOUN
iajs-877	65	15	conducted	conduct	VERB
iajs-877	65	16	in	in	ADP
iajs-877	65	17	iraq	iraq	PROPN
iajs-877	65	18	,	,	PUNCT
iajs-877	65	19	which	which	PRON
iajs-877	65	20	reported	report	VERB
iajs-877	65	21	that	that	SCONJ
iajs-877	65	22	an	an	DET
iajs-877	65	23	equal	equal	ADJ
iajs-877	65	24	ratio	ratio	NOUN
iajs-877	65	25	in	in	ADP
iajs-877	65	26	both	both	DET
iajs-877	65	27	males	male	NOUN
iajs-877	65	28	and	and	CCONJ
iajs-877	65	29	females	female	NOUN
iajs-877	65	30	[	[	X
iajs-877	65	31	13	13	NUM
iajs-877	65	32	]	]	PUNCT
iajs-877	65	33	.	.	PUNCT
iajs-877	66	1	our	our	PRON
iajs-877	66	2	results	result	NOUN
iajs-877	66	3	agreed	agree	VERB
iajs-877	66	4	with	with	ADP
iajs-877	66	5	a	a	DET
iajs-877	66	6	study	study	NOUN
iajs-877	66	7	conducted	conduct	VERB
iajs-877	66	8	in	in	ADP
iajs-877	66	9	turkey	turkey	NOUN
iajs-877	66	10	which	which	PRON
iajs-877	66	11	also	also	ADV
iajs-877	66	12	found	find	VERB
iajs-877	66	13	that	that	DET
iajs-877	66	14	male	male	NOUN
iajs-877	66	15	:	:	PUNCT
iajs-877	66	16	female	female	ADJ
iajs-877	66	17	ratio	ratio	NOUN
iajs-877	66	18	was	be	AUX
iajs-877	66	19	2:1	2:1	NUM
iajs-877	66	20	.	.	PUNCT
iajs-877	67	1	[	[	X
iajs-877	67	2	14	14	NUM
iajs-877	67	3	]	]	PUNCT
iajs-877	67	4	although	although	SCONJ
iajs-877	67	5	the	the	DET
iajs-877	67	6	results	result	NOUN
iajs-877	67	7	of	of	ADP
iajs-877	67	8	liver	liver	NOUN
iajs-877	67	9	function	function	NOUN
iajs-877	67	10	tests	test	NOUN
iajs-877	67	11	in	in	ADP
iajs-877	67	12	the	the	DET
iajs-877	67	13	current	current	ADJ
iajs-877	67	14	study	study	NOUN
iajs-877	67	15	was	be	AUX
iajs-877	67	16	higher	high	ADJ
iajs-877	67	17	in	in	ADP
iajs-877	67	18	hcv	hcv	NOUN
iajs-877	67	19	patients	patient	NOUN
iajs-877	67	20	than	than	ADP
iajs-877	67	21	those	those	PRON
iajs-877	67	22	in	in	ADP
iajs-877	67	23	hbv	hbv	NOUN
iajs-877	67	24	patients	patient	NOUN
iajs-877	67	25	,	,	PUNCT
iajs-877	67	26	statistical	statistical	ADJ
iajs-877	67	27	analysis	analysis	NOUN
iajs-877	67	28	revealed	reveal	VERB
iajs-877	67	29	that	that	SCONJ
iajs-877	67	30	there	there	PRON
iajs-877	67	31	was	be	VERB
iajs-877	67	32	no	no	DET
iajs-877	67	33	significant	significant	ADJ
iajs-877	67	34	difference	difference	NOUN
iajs-877	67	35	between	between	ADP
iajs-877	67	36	hbv	hbv	NOUN
iajs-877	67	37	and	and	CCONJ
iajs-877	67	38	hcv	hcv	NOUN
iajs-877	67	39	patients	patient	NOUN
iajs-877	67	40	concerning	concern	VERB
iajs-877	67	41	liver	liver	NOUN
iajs-877	67	42	function	function	NOUN
iajs-877	67	43	test	test	NOUN
iajs-877	67	44	.	.	PUNCT
iajs-877	68	1	these	these	DET
iajs-877	68	2	findings	finding	NOUN
iajs-877	68	3	disagreed	disagree	VERB
iajs-877	68	4	with	with	ADP
iajs-877	68	5	those	those	PRON
iajs-877	68	6	obtained	obtain	VERB
iajs-877	68	7	in	in	ADP
iajs-877	68	8	another	another	DET
iajs-877	68	9	study	study	NOUN
iajs-877	68	10	which	which	PRON
iajs-877	68	11	reported	report	VERB
iajs-877	68	12	that	that	SCONJ
iajs-877	68	13	hcv	hcv	NOUN
iajs-877	68	14	-	-	PUNCT
iajs-877	68	15	infected	infect	VERB
iajs-877	68	16	patients	patient	NOUN
iajs-877	68	17	presented	present	VERB
iajs-877	68	18	more	more	ADJ
iajs-877	68	19	liver	liver	NOUN
iajs-877	68	20	inflammation	inflammation	NOUN
iajs-877	68	21	(	(	PUNCT
iajs-877	68	22	higher	high	ADJ
iajs-877	68	23	ast	ast	NOUN
iajs-877	68	24	,	,	PUNCT
iajs-877	68	25	alt	alt	VERB
iajs-877	68	26	and	and	CCONJ
iajs-877	68	27	alp	alp	PROPN
iajs-877	68	28	)	)	PUNCT
iajs-877	68	29	than	than	ADP
iajs-877	68	30	hbv	hbv	NOUN
iajs-877	68	31	-	-	PUNCT
iajs-877	68	32	infected	infect	VERB
iajs-877	68	33	patients	patient	NOUN
iajs-877	68	34	.	.	PUNCT
iajs-877	69	1	this	this	DET
iajs-877	69	2	difference	difference	NOUN
iajs-877	69	3	in	in	ADP
iajs-877	69	4	liver	liver	NOUN
iajs-877	69	5	inflammation	inflammation	NOUN
iajs-877	69	6	can	can	AUX
iajs-877	69	7	be	be	AUX
iajs-877	69	8	attributed	attribute	VERB
iajs-877	69	9	to	to	ADP
iajs-877	69	10	the	the	DET
iajs-877	69	11	higher	high	ADJ
iajs-877	69	12	percentage	percentage	NOUN
iajs-877	69	13	of	of	ADP
iajs-877	69	14	previous	previous	ADJ
iajs-877	69	15	antiviral	antiviral	ADJ
iajs-877	69	16	treatment	treatment	NOUN
iajs-877	69	17	and	and	CCONJ
iajs-877	69	18	the	the	DET
iajs-877	69	19	higher	high	ADJ
iajs-877	69	20	response	response	NOUN
iajs-877	69	21	rate	rate	NOUN
iajs-877	69	22	to	to	ADP
iajs-877	69	23	therapy	therapy	NOUN
iajs-877	69	24	in	in	ADP
iajs-877	69	25	the	the	DET
iajs-877	69	26	hbv	hbv	NOUN
iajs-877	69	27	group	group	NOUN
iajs-877	69	28	compared	compare	VERB
iajs-877	69	29	with	with	ADP
iajs-877	69	30	the	the	DET
iajs-877	69	31	hcv	hcv	PROPN
iajs-877	69	32	group	group	NOUN
iajs-877	69	33	[	[	X
iajs-877	69	34	15	15	NUM
iajs-877	69	35	]	]	PUNCT
iajs-877	69	36	.	.	PUNCT
iajs-877	70	1	it	it	PRON
iajs-877	70	2	is	be	AUX
iajs-877	70	3	well	well	ADV
iajs-877	70	4	known	know	VERB
iajs-877	70	5	that	that	SCONJ
iajs-877	70	6	chronic	chronic	ADJ
iajs-877	70	7	hepatitis	hepatitis	NOUN
iajs-877	70	8	c	c	PROPN
iajs-877	70	9	is	be	AUX
iajs-877	70	10	associated	associate	VERB
iajs-877	70	11	with	with	ADP
iajs-877	70	12	a	a	DET
iajs-877	70	13	wide	wide	ADJ
iajs-877	70	14	variation	variation	NOUN
iajs-877	70	15	in	in	ADP
iajs-877	70	16	alt	alt	ADJ
iajs-877	70	17	,	,	PUNCT
iajs-877	70	18	from	from	ADP
iajs-877	70	19	normal	normal	ADJ
iajs-877	70	20	alt	alt	NOUN
iajs-877	70	21	to	to	ADP
iajs-877	70	22	persistent	persistent	ADJ
iajs-877	70	23	elevation	elevation	NOUN
iajs-877	70	24	of	of	ADP
iajs-877	70	25	alt	alt	ADJ
iajs-877	70	26	,	,	PUNCT
iajs-877	70	27	although	although	SCONJ
iajs-877	70	28	studies	study	NOUN
iajs-877	70	29	have	have	VERB
iajs-877	70	30	ibn	ibn	PROPN
iajs-877	70	31	alhaitham	alhaitham	NOUN
iajs-877	71	1	j.	j.	PROPN
iajs-877	72	1	fo	fo	ADP
iajs-877	72	2	r	r	NOUN
iajs-877	72	3	pure	pure	ADJ
iajs-877	72	4	&	&	CCONJ
iajs-877	72	5	appl	appl	PROPN
iajs-877	72	6	.	.	PUNCT
iajs-877	73	1	sci	sci	PROPN
iajs-877	73	2	.	.	PROPN
iajs-877	74	1	vo	vo	INTJ
iajs-877	74	2	l.24	l.24	PROPN
iajs-877	74	3	(	(	PUNCT
iajs-877	74	4	1	1	NUM
iajs-877	74	5	)	)	PUNCT
iajs-877	74	6	2011	2011	NUM
iajs-877	74	7	shown	show	VERB
iajs-877	74	8	that	that	SCONJ
iajs-877	74	9	patients	patient	NOUN
iajs-877	74	10	with	with	ADP
iajs-877	74	11	persistently	persistently	ADV
iajs-877	74	12	normal	normal	ADJ
iajs-877	74	13	alt	alt	NOUN
iajs-877	74	14	usually	usually	ADV
iajs-877	74	15	have	have	VERB
iajs-877	74	16	slower	slow	ADJ
iajs-877	74	17	progression	progression	NOUN
iajs-877	74	18	and	and	CCONJ
iajs-877	74	19	lower	low	ADJ
iajs-877	74	20	prevalence	prevalence	NOUN
iajs-877	74	21	of	of	ADP
iajs-877	74	22	cirrhosis	cirrhosis	NOUN
iajs-877	74	23	.	.	PUNCT
iajs-877	75	1	[	[	X
iajs-877	75	2	16	16	NUM
iajs-877	75	3	]	]	PUNCT
iajs-877	75	4	in	in	ADP
iajs-877	75	5	this	this	DET
iajs-877	75	6	study	study	NOUN
iajs-877	75	7	we	we	PRON
iajs-877	75	8	noted	note	VERB
iajs-877	75	9	that	that	SCONJ
iajs-877	75	10	hemoglobin	hemoglobin	NOUN
iajs-877	75	11	concentration	concentration	NOUN
iajs-877	75	12	and	and	CCONJ
iajs-877	75	13	total	total	ADJ
iajs-877	75	14	wbc	wbc	PROPN
iajs-877	75	15	count	count	NOUN
iajs-877	75	16	were	be	AUX
iajs-877	75	17	different	different	ADJ
iajs-877	75	18	in	in	ADP
iajs-877	75	19	hbv	hbv	NOUN
iajs-877	75	20	and	and	CCONJ
iajs-877	75	21	hcv	hcv	NOUN
iajs-877	75	22	patients	patient	NOUN
iajs-877	75	23	.	.	PUNCT
iajs-877	76	1	hepatitis	hepatitis	PROPN
iajs-877	76	2	c	c	PROPN
iajs-877	76	3	patients	patient	NOUN
iajs-877	76	4	included	include	VERB
iajs-877	76	5	in	in	ADP
iajs-877	76	6	this	this	DET
iajs-877	76	7	study	study	NOUN
iajs-877	76	8	had	have	VERB
iajs-877	76	9	lower	low	ADJ
iajs-877	76	10	total	total	ADJ
iajs-877	76	11	hemoglobin	hemoglobin	NOUN
iajs-877	76	12	concentration	concentration	NOUN
iajs-877	76	13	and	and	CCONJ
iajs-877	76	14	total	total	ADJ
iajs-877	76	15	wbc	wbc	ADJ
iajs-877	76	16	count	count	NOUN
iajs-877	76	17	than	than	ADP
iajs-877	76	18	those	those	PRON
iajs-877	76	19	found	find	VERB
iajs-877	76	20	in	in	ADP
iajs-877	76	21	hepatitis	hepatitis	PROPN
iajs-877	76	22	b	b	PROPN
iajs-877	76	23	patients	patient	NOUN
iajs-877	76	24	with	with	ADP
iajs-877	76	25	a	a	DET
iajs-877	76	26	significant	significant	ADJ
iajs-877	76	27	difference	difference	NOUN
iajs-877	76	28	.	.	PUNCT
iajs-877	77	1	these	these	DET
iajs-877	77	2	results	result	NOUN
iajs-877	77	3	were	be	AUX
iajs-877	77	4	similar	similar	ADJ
iajs-877	77	5	to	to	ADP
iajs-877	77	6	those	those	PRON
iajs-877	77	7	obtained	obtain	VERB
iajs-877	77	8	in	in	ADP
iajs-877	77	9	another	another	DET
iajs-877	77	10	study	study	NOUN
iajs-877	77	11	which	which	PRON
iajs-877	77	12	reported	report	VERB
iajs-877	77	13	that	that	SCONJ
iajs-877	77	14	hcv	hcv	VERB
iajs-877	77	15	positive	positive	ADJ
iajs-877	77	16	patients	patient	NOUN
iajs-877	77	17	have	have	VERB
iajs-877	77	18	lower	low	ADJ
iajs-877	77	19	hemoglobin	hemoglobin	NOUN
iajs-877	77	20	and	and	CCONJ
iajs-877	77	21	white	white	ADJ
iajs-877	77	22	blood	blood	NOUN
iajs-877	77	23	cell	cell	NOUN
iajs-877	77	24	count	count	NOUN
iajs-877	77	25	.	.	PUNCT
iajs-877	78	1	[	[	X
iajs-877	78	2	17	17	NUM
iajs-877	78	3	]	]	PUNCT
iajs-877	78	4	nevertheless	nevertheless	ADV
iajs-877	78	5	the	the	DET
iajs-877	78	6	current	current	ADJ
iajs-877	78	7	results	result	NOUN
iajs-877	78	8	were	be	AUX
iajs-877	78	9	consistent	consistent	ADJ
iajs-877	78	10	with	with	ADP
iajs-877	78	11	the	the	DET
iajs-877	78	12	data	datum	NOUN
iajs-877	78	13	reported	report	VERB
iajs-877	78	14	by	by	ADP
iajs-877	78	15	a	a	DET
iajs-877	78	16	study	study	NOUN
iajs-877	78	17	which	which	PRON
iajs-877	78	18	concluded	conclude	VERB
iajs-877	78	19	that	that	SCONJ
iajs-877	78	20	regarding	regard	VERB
iajs-877	78	21	liver	liver	NOUN
iajs-877	78	22	disease	disease	NOUN
iajs-877	78	23	severity	severity	NOUN
iajs-877	78	24	,	,	PUNCT
iajs-877	78	25	chronic	chronic	ADJ
iajs-877	78	26	hepatitis	hepatitis	PROPN
iajs-877	78	27	b	b	PROPN
iajs-877	78	28	compared	compare	VERB
iajs-877	78	29	with	with	ADP
iajs-877	78	30	chronic	chronic	ADJ
iajs-877	78	31	hepatitis	hepatitis	NOUN
iajs-877	78	32	c	c	PROPN
iajs-877	78	33	patients	patient	NOUN
iajs-877	78	34	had	have	VERB
iajs-877	78	35	significantly	significantly	ADV
iajs-877	78	36	lower	low	ADJ
iajs-877	78	37	white	white	ADJ
iajs-877	78	38	blood	blood	NOUN
iajs-877	78	39	cell	cell	NOUN
iajs-877	78	40	and	and	CCONJ
iajs-877	78	41	platelet	platelet	NOUN
iajs-877	78	42	counts	count	NOUN
iajs-877	78	43	,	,	PUNCT
iajs-877	78	44	but	but	CCONJ
iajs-877	78	45	similar	similar	ADJ
iajs-877	78	46	biochemical	biochemical	ADJ
iajs-877	78	47	(	(	PUNCT
iajs-877	78	48	aminotransferases	aminotransferase	NOUN
iajs-877	78	49	levels	level	NOUN
iajs-877	78	50	)	)	PUNCT
iajs-877	78	51	and	and	CCONJ
iajs-877	78	52	histological	histological	ADJ
iajs-877	78	53	(	(	PUNCT
iajs-877	78	54	grading	grade	VERB
iajs-877	78	55	and	and	CCONJ
iajs-877	78	56	staging	staging	NOUN
iajs-877	78	57	)	)	PUNCT
iajs-877	78	58	findings	finding	NOUN
iajs-877	78	59	as	as	ADV
iajs-877	78	60	well	well	ADV
iajs-877	78	61	as	as	ADP
iajs-877	78	62	a	a	DET
iajs-877	78	63	similar	similar	ADJ
iajs-877	78	64	prevalence	prevalence	NOUN
iajs-877	78	65	of	of	ADP
iajs-877	78	66	all	all	DET
iajs-877	78	67	other	other	ADJ
iajs-877	78	68	thrombophilic	thrombophilic	NOUN
iajs-877	78	69	or	or	CCONJ
iajs-877	78	70	coagulation	coagulation	NOUN
iajs-877	78	71	factors	factor	NOUN
iajs-877	78	72	[	[	X
iajs-877	78	73	18	18	NUM
iajs-877	78	74	]	]	PUNCT
iajs-877	78	75	.	.	PUNCT
iajs-877	79	1	this	this	DET
iajs-877	79	2	variation	variation	NOUN
iajs-877	79	3	may	may	AUX
iajs-877	79	4	be	be	AUX
iajs-877	79	5	due	due	ADJ
iajs-877	79	6	to	to	ADP
iajs-877	79	7	the	the	DET
iajs-877	79	8	following	follow	VERB
iajs-877	79	9	factors	factor	NOUN
iajs-877	79	10	,	,	PUNCT
iajs-877	79	11	first	first	ADJ
iajs-877	79	12	patients	patient	NOUN
iajs-877	79	13	in	in	ADP
iajs-877	79	14	our	our	PRON
iajs-877	79	15	study	study	NOUN
iajs-877	79	16	were	be	AUX
iajs-877	79	17	younger	young	ADJ
iajs-877	79	18	than	than	ADP
iajs-877	79	19	those	those	PRON
iajs-877	79	20	in	in	ADP
iajs-877	79	21	the	the	DET
iajs-877	79	22	other	other	ADJ
iajs-877	79	23	study	study	NOUN
iajs-877	79	24	.	.	PUNCT
iajs-877	80	1	second	second	ADJ
iajs-877	80	2	geographic	geographic	ADJ
iajs-877	80	3	variation	variation	NOUN
iajs-877	80	4	in	in	ADP
iajs-877	80	5	hbv	hbv	NOUN
iajs-877	80	6	genotypes	genotype	NOUN
iajs-877	80	7	in	in	ADP
iajs-877	80	8	study	study	NOUN
iajs-877	80	9	population	population	NOUN
iajs-877	80	10	would	would	AUX
iajs-877	80	11	influence	influence	VERB
iajs-877	80	12	the	the	DET
iajs-877	80	13	prevalence	prevalence	NOUN
iajs-877	80	14	of	of	ADP
iajs-877	80	15	chronic	chronic	ADJ
iajs-877	80	16	hepatitis	hepatitis	PROPN
iajs-877	80	17	b.	b.	PROPN
iajs-877	80	18	another	another	DET
iajs-877	80	19	factor	factor	NOUN
iajs-877	80	20	is	be	AUX
iajs-877	80	21	that	that	SCONJ
iajs-877	80	22	the	the	DET
iajs-877	80	23	cause	cause	NOUN
iajs-877	80	24	may	may	AUX
iajs-877	80	25	also	also	ADV
iajs-877	80	26	be	be	AUX
iajs-877	80	27	nutritional	nutritional	ADJ
iajs-877	80	28	or	or	CCONJ
iajs-877	80	29	infectious	infectious	ADJ
iajs-877	80	30	,	,	PUNCT
iajs-877	80	31	finally	finally	ADV
iajs-877	80	32	difference	difference	VERB
iajs-877	80	33	in	in	ADP
iajs-877	80	34	sample	sample	NOUN
iajs-877	80	35	size	size	NOUN
iajs-877	80	36	.	.	PUNCT
iajs-877	81	1	further	further	ADJ
iajs-877	81	2	studies	study	NOUN
iajs-877	81	3	on	on	ADP
iajs-877	81	4	a	a	DET
iajs-877	81	5	much	much	ADV
iajs-877	81	6	larger	large	ADJ
iajs-877	81	7	scale	scale	NOUN
iajs-877	81	8	are	be	AUX
iajs-877	81	9	needed	need	VERB
iajs-877	81	10	to	to	PART
iajs-877	81	11	evaluate	evaluate	VERB
iajs-877	81	12	other	other	ADJ
iajs-877	81	13	factors	factor	NOUN
iajs-877	81	14	that	that	PRON
iajs-877	81	15	might	might	AUX
iajs-877	81	16	affect	affect	VERB
iajs-877	81	17	the	the	DET
iajs-877	81	18	relationship	relationship	NOUN
iajs-877	81	19	between	between	ADP
iajs-877	81	20	hbv	hbv	NOUN
iajs-877	81	21	and	and	CCONJ
iajs-877	81	22	hcv	hcv	NOUN
iajs-877	81	23	infection	infection	NOUN
iajs-877	81	24	with	with	ADP
iajs-877	81	25	respect	respect	NOUN
iajs-877	81	26	to	to	ADP
iajs-877	81	27	hemoglobin	hemoglobin	NOUN
iajs-877	81	28	,	,	PUNCT
iajs-877	81	29	hematocrit	hematocrit	PROPN
iajs-877	81	30	levels	level	NOUN
iajs-877	81	31	,	,	PUNCT
iajs-877	81	32	differential	differential	ADJ
iajs-877	81	33	leucocyte	leucocyte	NOUN
iajs-877	81	34	count	count	NOUN
iajs-877	81	35	,	,	PUNCT
iajs-877	81	36	phylogenic	phylogenic	ADJ
iajs-877	81	37	analysis	analysis	NOUN
iajs-877	81	38	for	for	ADP
iajs-877	81	39	viral	viral	ADJ
iajs-877	81	40	genotypes	genotype	NOUN
iajs-877	81	41	,	,	PUNCT
iajs-877	81	42	viral	viral	ADJ
iajs-877	81	43	titers	titer	NOUN
iajs-877	81	44	,	,	PUNCT
iajs-877	81	45	serum	serum	NOUN
iajs-877	81	46	ferritin	ferritin	ADJ
iajs-877	81	47	level	level	NOUN
iajs-877	81	48	and	and	CCONJ
iajs-877	81	49	the	the	DET
iajs-877	81	50	degree	degree	NOUN
iajs-877	81	51	of	of	ADP
iajs-877	81	52	hepatic	hepatic	ADJ
iajs-877	81	53	injury	injury	NOUN
iajs-877	81	54	.	.	PUNCT
iajs-877	82	1	references	reference	NOUN
iajs-877	82	2	1purcell	1purcell	NUM
iajs-877	82	3	,	,	PUNCT
iajs-877	82	4	r.	r.	PROPN
iajs-877	82	5	h.(1994	h.(1994	PROPN
iajs-877	82	6	)	)	PUNCT
iajs-877	82	7	,	,	PUNCT
iajs-877	82	8	hepatitis	hepatitis	NOUN
iajs-877	82	9	viruses	virus	NOUN
iajs-877	82	10	;	;	PUNCT
iajs-877	82	11	changing	change	VERB
iajs-877	82	12	patterns	pattern	NOUN
iajs-877	82	13	of	of	ADP
iajs-877	82	14	human	human	ADJ
iajs-877	82	15	disease	disease	NOUN
iajs-877	82	16	.	.	PUNCT
iajs-877	83	1	proc	proc	PROPN
iajs-877	83	2	natl	natl	PROPN
iajs-877	83	3	acad	acad	PROPN
iajs-877	83	4	sci	sci	PROPN
iajs-877	83	5	usa:91	usa:91	PROPN
iajs-877	83	6	;	;	PUNCT
iajs-877	83	7	2041	2041	NUM
iajs-877	83	8	-	-	SYM
iajs-877	83	9	6	6	NUM
iajs-877	83	10	.	.	PUNCT
iajs-877	84	1	2fujiwara	2fujiwara	NUM
iajs-877	84	2	,	,	PUNCT
iajs-877	84	3	a.	a.	NOUN
iajs-877	84	4	;	;	PUNCT
iajs-877	84	5	sakaguchi	sakaguchi	ADV
iajs-877	84	6	,	,	PUNCT
iajs-877	84	7	k.;fujioka	k.;fujioka	PROPN
iajs-877	84	8	,	,	PUNCT
iajs-877	84	9	s.	s.	PROPN
iajs-877	84	10	;	;	PUNCT
iajs-877	84	11	iwasaki	iwasaki	PROPN
iajs-877	84	12	,	,	PUNCT
iajs-877	84	13	y.	y.	PROPN
iajs-877	84	14	;	;	PUNCT
iajs-877	84	15	senoh	senoh	NOUN
iajs-877	84	16	,	,	PUNCT
iajs-877	84	17	t.	t.	PROPN
iajs-877	84	18	;	;	PUNCT
iajs-877	84	19	nishimura	nishimura	PROPN
iajs-877	84	20	,	,	PUNCT
iajs-877	84	21	m.	m.	NOUN
iajs-877	84	22	;	;	PUNCT
iajs-877	84	23	terao	terao	PROPN
iajs-877	84	24	,	,	PUNCT
iajs-877	84	25	m	m	PROPN
iajs-877	84	26	.	.	PUNCT
iajs-877	84	27	and	and	CCONJ
iajs-877	84	28	shiratori	shiratori	ADV
iajs-877	84	29	,	,	PUNCT
iajs-877	84	30	y.	y.	PROPN
iajs-877	84	31	(	(	PUNCT
iajs-877	84	32	2008	2008	NUM
iajs-877	84	33	)	)	PUNCT
iajs-877	84	34	fibrosis	fibrosis	NOUN
iajs-877	84	35	p	p	NOUN
iajs-877	84	36	rogression	rogression	NOUN
iajs-877	84	37	rates	rate	NOUN
iajs-877	84	38	between	between	ADP
iajs-877	84	39	chronic	chronic	ADJ
iajs-877	84	40	hepatitis	hepatitis	PROPN
iajs-877	84	41	b	b	PROPN
iajs-877	84	42	and	and	CCONJ
iajs-877	84	43	c	c	PROPN
iajs-877	84	44	patients	patient	NOUN
iajs-877	84	45	with	with	ADP
iajs-877	84	46	elevated	elevated	ADJ
iajs-877	84	47	alanine	alanine	NOUN
iajs-877	84	48	aminotransferase	aminotransferase	PROPN
iajs-877	84	49	levels	level	NOUN
iajs-877	84	50	.	.	PUNCT
iajs-877	85	1	j	j	PROPN
iajs-877	85	2	gastroenterol	gastroenterol	PROPN
iajs-877	85	3	;	;	PUNCT
iajs-877	85	4	43:484–491	43:484–491	PROPN
iajs-877	85	5	.	.	PUNCT
iajs-877	86	1	3park	3park	NUM
iajs-877	86	2	,	,	PUNCT
iajs-877	86	3	k.s	k.s	PROPN
iajs-877	86	4	.	.	PROPN
iajs-877	86	5	;	;	PUNCT
iajs-877	86	6	lee	lee	PROPN
iajs-877	86	7	,	,	PUNCT
iajs-877	86	8	y.s	y.s	PROPN
iajs-877	86	9	.	.	PROPN
iajs-877	86	10	and	and	CCONJ
iajs-877	86	11	lee	lee	PROPN
iajs-877	86	12	,	,	PUNCT
iajs-877	86	13	s.k	s.k	PROPN
iajs-877	86	14	.	.	PROPN
iajs-877	86	15	(	(	PUNCT
iajs-877	86	16	2003	2003	NUM
iajs-877	86	17	)	)	PUNCT
iajs-877	86	18	a	a	DET
iajs-877	86	19	study	study	NOUN
iajs-877	86	20	on	on	ADP
iajs-877	86	21	markers	marker	NOUN
iajs-877	86	22	of	of	ADP
iajs-877	86	23	viral	viral	ADJ
iajs-877	86	24	hepatitis	hepatitis	NOUN
iajs-877	86	25	in	in	ADP
iajs-877	86	26	adults	adult	NOUN
iajs-877	86	27	living	live	VERB
iajs-877	86	28	in	in	ADP
iajs-877	86	29	daegu	daegu	NOUN
iajs-877	86	30	and	and	CCONJ
iajs-877	86	31	gyungbuk	gyungbuk	NOUN
iajs-877	86	32	area	area	NOUN
iajs-877	86	33	.	.	PUNCT
iajs-877	87	1	korean	korean	PROPN
iajs-877	87	2	j	j	PROPN
iajs-877	87	3	gastroenterol;41:473	gastroenterol;41:473	PROPN
iajs-877	87	4	-	-	PUNCT
iajs-877	87	5	479	479	NUM
iajs-877	87	6	.	.	PUNCT
iajs-877	88	1	4lee	4lee	NUM
iajs-877	88	2	,	,	PUNCT
iajs-877	88	3	w.m	w.m	PROPN
iajs-877	88	4	.	.	PUNCT
iajs-877	88	5	(	(	PUNCT
iajs-877	88	6	1997),hepatitis	1997),hepatitis	NUM
iajs-877	88	7	b	b	PROPN
iajs-877	88	8	virus	virus	NOUN
iajs-877	88	9	infection	infection	NOUN
iajs-877	88	10	.	.	PUNCT
iajs-877	89	1	n	n	PROPN
iajs-877	89	2	engl	engl	PROPN
iajs-877	89	3	j	j	PROPN
iajs-877	89	4	med	med	PROPN
iajs-877	89	5	;	;	PUNCT
iajs-877	89	6	337	337	NUM
iajs-877	89	7	:	:	PUNCT
iajs-877	89	8	1733	1733	NUM
iajs-877	89	9	-	-	SYM
iajs-877	89	10	45	45	NUM
iajs-877	89	11	.	.	PUNCT
iajs-877	90	1	5andre	5andre	NUM
iajs-877	90	2	,	,	PUNCT
iajs-877	90	3	f.	f.	PROPN
iajs-877	90	4	(	(	PUNCT
iajs-877	90	5	2000),hepatitis	2000),hepatitis	NUM
iajs-877	90	6	b	b	NOUN
iajs-877	90	7	epidemiology	epidemiology	NOUN
iajs-877	90	8	in	in	ADP
iajs-877	90	9	asia	asia	PROPN
iajs-877	90	10	,	,	PUNCT
iajs-877	90	11	the	the	DET
iajs-877	90	12	middle	middle	PROPN
iajs-877	90	13	east	east	PROPN
iajs-877	90	14	and	and	CCONJ
iajs-877	90	15	africa	africa	PROPN
iajs-877	90	16	.	.	PUNCT
iajs-877	91	1	vaccine	vaccine	NOUN
iajs-877	91	2	;	;	PUNCT
iajs-877	91	3	18	18	NUM
iajs-877	91	4	:	:	PUNCT
iajs-877	91	5	s20	s20	VERB
iajs-877	91	6	-	-	SYM
iajs-877	91	7	2	2	NUM
iajs-877	91	8	.	.	PUNCT
iajs-877	92	1	6international	6international	NUM
iajs-877	92	2	congress	congress	NOUN
iajs-877	92	3	on	on	ADP
iajs-877	92	4	viral	viral	ADJ
iajs-877	92	5	hepatitis	hepatitis	NOUN
iajs-877	92	6	a	a	PRON
iajs-877	92	7	and	and	CCONJ
iajs-877	92	8	b	b	NOUN
iajs-877	92	9	:	:	PUNCT
iajs-877	92	10	experience	experience	NOUN
iajs-877	92	11	in	in	ADP
iajs-877	92	12	education	education	NOUN
iajs-877	92	13	and	and	CCONJ
iajs-877	92	14	prevention	prevention	NOUN
iajs-877	92	15	,	,	PUNCT
iajs-877	92	16	warsaw	warsaw	PROPN
iajs-877	92	17	,	,	PUNCT
iajs-877	92	18	pologne	pologne	PROPN
iajs-877	92	19	(	(	PUNCT
iajs-877	92	20	18/10/1998	18/10/1998	NUM
iajs-877	92	21	)	)	PUNCT
iajs-877	92	22	2000,vol.18(121p.)(8ref.):s20	2000,vol.18(121p.)(8ref.):s20	NOUN
iajs-877	92	23	-	-	SYM
iajs-877	92	24	22	22	NUM
iajs-877	92	25	7qirbi	7qirbi	PROPN
iajs-877	92	26	,	,	PUNCT
iajs-877	92	27	n.	n.	NOUN
iajs-877	92	28	and	and	CCONJ
iajs-877	92	29	a.j	a.j	PROPN
iajs-877	92	30	.	.	PROPN
iajs-877	93	1	(	(	PUNCT
iajs-877	93	2	2001),hall	2001),hall	NUM
iajs-877	93	3	epidemiology	epidemiology	NOUN
iajs-877	93	4	of	of	ADP
iajs-877	93	5	hepatitis	hepatitis	PROPN
iajs-877	93	6	b	b	PROPN
iajs-877	93	7	virus	virus	NOUN
iajs-877	93	8	infection	infection	NOUN
iajs-877	93	9	in	in	ADP
iajs-877	93	10	the	the	DET
iajs-877	93	11	middle	middle	PROPN
iajs-877	93	12	east	east	PROPN
iajs-877	93	13	eastern	eastern	PROPN
iajs-877	93	14	mediterranean	mediterranean	PROPN
iajs-877	93	15	health	health	PROPN
iajs-877	93	16	journal	journal	PROPN
iajs-877	93	17	,	,	PUNCT
iajs-877	93	18	november	november	PROPN
iajs-877	93	19	,	,	PUNCT
iajs-877	93	20	:	:	PUNCT
iajs-877	93	21	1034	1034	NUM
iajs-877	93	22	-	-	SYM
iajs-877	93	23	1045	1045	NUM
iajs-877	93	24	8alavian	8alavian	NUM
iajs-877	93	25	,	,	PUNCT
iajs-877	93	26	s.m	s.m	PROPN
iajs-877	93	27	.	.	PROPN
iajs-877	93	28	;	;	PUNCT
iajs-877	93	29	adibi	adibi	PROPN
iajs-877	93	30	,	,	PUNCT
iajs-877	93	31	p.and	p.and	PROPN
iajs-877	93	32	zali	zali	PROPN
iajs-877	93	33	,	,	PUNCT
iajs-877	93	34	m.r	m.r	PROPN
iajs-877	93	35	.	.	PUNCT
iajs-877	94	1	(	(	PUNCT
iajs-877	94	2	2005)hepatitis	2005)hepatitis	NUM
iajs-877	94	3	c	c	PROPN
iajs-877	94	4	virus	virus	NOUN
iajs-877	94	5	in	in	ADP
iajs-877	94	6	iran	iran	PROPN
iajs-877	94	7	:	:	PUNCT
iajs-877	94	8	epidemiology	epidemiology	NOUN
iajs-877	94	9	of	of	ADP
iajs-877	94	10	an	an	DET
iajs-877	94	11	emerging	emerge	VERB
iajs-877	94	12	infection	infection	NOUN
iajs-877	94	13	.	.	PUNCT
iajs-877	95	1	arch	arch	PROPN
iajs-877	95	2	iranian	iranian	PROPN
iajs-877	95	3	med	med	PROPN
iajs-877	95	4	;	;	PUNCT
iajs-877	95	5	8	8	NUM
iajs-877	95	6	:	:	SYM
iajs-877	95	7	84	84	NUM
iajs-877	95	8	-	-	SYM
iajs-877	95	9	90	90	NUM
iajs-877	95	10	.	.	PUNCT
iajs-877	96	1	9abdel	9abdel	X
iajs-877	96	2	-	-	PUNCT
iajs-877	96	3	aziz	aziz	PROPN
iajs-877	96	4	,	,	PUNCT
iajs-877	96	5	f.	f.	PROPN
iajs-877	96	6	;	;	PUNCT
iajs-877	96	7	habib	habib	PROPN
iajs-877	96	8	,	,	PUNCT
iajs-877	96	9	m.	m.	NOUN
iajs-877	96	10	;	;	PUNCT
iajs-877	96	11	mohamed	mohamed	PROPN
iajs-877	96	12	,	,	PUNCT
iajs-877	96	13	m.k	m.k	PROPN
iajs-877	96	14	.	.	PUNCT
iajs-877	96	15	;	;	PUNCT
iajs-877	96	16	abdel	abdel	PROPN
iajs-877	96	17	-	-	PUNCT
iajs-877	96	18	hamid	hamid	PROPN
iajs-877	96	19	,	,	PUNCT
iajs-877	96	20	m.	m.	NOUN
iajs-877	96	21	;	;	PUNCT
iajs-877	96	22	gamil	gamil	PROPN
iajs-877	96	23	,	,	PUNCT
iajs-877	96	24	f.	f.	PROPN
iajs-877	96	25	;	;	PUNCT
iajs-877	96	26	madkour	madkour	PROPN
iajs-877	96	27	,	,	PUNCT
iajs-877	96	28	s.	s.	PROPN
iajs-877	96	29	mikhail	mikhail	PROPN
iajs-877	96	30	,	,	PUNCT
iajs-877	96	31	n.	n.	PROPN
iajs-877	96	32	;	;	PUNCT
iajs-877	96	33	thomas	thomas	PROPN
iajs-877	96	34	,	,	PUNCT
iajs-877	96	35	d.;fix	d.;fix	NOUN
iajs-877	96	36	,	,	PUNCT
iajs-877	96	37	a.d	a.d	PROPN
iajs-877	96	38	.	.	PROPN
iajs-877	96	39	;	;	PUNCT
iajs-877	96	40	strickland	strickland	PROPN
iajs-877	96	41	,	,	PUNCT
iajs-877	96	42	g.t	g.t	PROPN
iajs-877	96	43	.	.	PROPN
iajs-877	96	44	;	;	PUNCT
iajs-877	96	45	anwar	anwar	PROPN
iajs-877	96	46	,	,	PUNCT
iajs-877	96	47	w.and	w.and	NOUN
iajs-877	96	48	sallam	sallam	NOUN
iajs-877	96	49	,	,	PUNCT
iajs-877	96	50	i.	i.	PROPN
iajs-877	96	51	(	(	PUNCT
iajs-877	96	52	2000),hepatitis	2000),hepatitis	NUM
iajs-877	96	53	c	c	PROPN
iajs-877	96	54	virus	virus	NOUN
iajs-877	96	55	(	(	PUNCT
iajs-877	96	56	hcv	hcv	NOUN
iajs-877	96	57	)	)	PUNCT
iajs-877	96	58	infection	infection	NOUN
iajs-877	96	59	in	in	ADP
iajs-877	96	60	a	a	DET
iajs-877	96	61	community	community	NOUN
iajs-877	96	62	in	in	ADP
iajs-877	96	63	the	the	DET
iajs-877	96	64	nile	nile	PROPN
iajs-877	96	65	delta	delta	PROPN
iajs-877	96	66	:	:	PUNCT
iajs-877	96	67	population	population	NOUN
iajs-877	96	68	description	description	NOUN
iajs-877	96	69	and	and	CCONJ
iajs-877	96	70	hcv	hcv	PROPN
iajs-877	96	71	prevalence	prevalence	NOUN
iajs-877	96	72	.	.	PUNCT
iajs-877	97	1	hepatology	hepatology	NOUN
iajs-877	97	2	;	;	PUNCT
iajs-877	97	3	32	32	NUM
iajs-877	97	4	:	:	SYM
iajs-877	97	5	111	111	NUM
iajs-877	97	6	-	-	SYM
iajs-877	97	7	115	115	NUM
iajs-877	97	8	10koff	10koff	NUM
iajs-877	97	9	,	,	PUNCT
iajs-877	97	10	r.s	r.s	PROPN
iajs-877	97	11	.	.	PROPN
iajs-877	98	1	(	(	PUNCT
iajs-877	98	2	2004)."acute	2004)."acute	NUM
iajs-877	98	3	viral	viral	ADJ
iajs-877	98	4	hepatitis	hepatitis	NOUN
iajs-877	98	5	.	.	PUNCT
iajs-877	98	6	"	"	PUNCT
iajs-877	99	1	in	in	ADP
iajs-877	99	2	:	:	PUNCT
iajs-877	99	3	clinical	clinical	ADJ
iajs-877	99	4	practice	practice	NOUN
iajs-877	99	5	of	of	ADP
iajs-877	99	6	gastroenterology	gastroenterology	NOUN
iajs-877	99	7	.	.	PUNCT
iajs-877	100	1	"by	"by	PROPN
iajs-877	100	2	:	:	PUNCT
iajs-877	100	3	lawrence	lawrence	PROPN
iajs-877	100	4	j	j	PROPN
iajs-877	100	5	,	,	PUNCT
iajs-877	100	6	brandt	brandt	PROPN
iajs-877	100	7	,	,	PUNCT
iajs-877	100	8	churchil	churchil	PROPN
iajs-877	100	9	livingstone	livingstone	PROPN
iajs-877	100	10	co.	co.	PROPN
iajs-877	100	11	vol	vol	NOUN
iajs-877	100	12	11.pp:831	11.pp:831	NUM
iajs-877	100	13	-	-	SYM
iajs-877	100	14	839	839	NUM
iajs-877	100	15	.	.	PUNCT
iajs-877	101	1	11	11	NUM
iajs-877	101	2	-	-	PUNCT
iajs-877	101	3	statistics	statistic	NOUN
iajs-877	101	4	for	for	ADP
iajs-877	101	5	windows	window	NOUN
iajs-877	101	6	(	(	PUNCT
iajs-877	101	7	1999)"edition	1999)"edition	NOUN
iajs-877	101	8	99	99	NUM
iajs-877	101	9	"	"	PUNCT
iajs-877	101	10	,	,	PUNCT
iajs-877	101	11	,	,	PUNCT
iajs-877	101	12	kernel	kernel	PROPN
iajs-877	101	13	release	release	PROPN
iajs-877	101	14	.	.	PUNCT
iajs-877	102	1	12sabri	12sabri	NUM
iajs-877	102	2	,	,	PUNCT
iajs-877	102	3	h.j	h.j	PROPN
iajs-877	102	4	.	.	PROPN
iajs-877	102	5	(	(	PUNCT
iajs-877	102	6	2003	2003	NUM
iajs-877	102	7	)	)	PUNCT
iajs-877	102	8	"	"	PUNCT
iajs-877	102	9	the	the	DET
iajs-877	102	10	diagnostic	diagnostic	ADJ
iajs-877	102	11	role	role	NOUN
iajs-877	102	12	of	of	ADP
iajs-877	102	13	liver	liver	NOUN
iajs-877	102	14	biopsy	biopsy	NOUN
iajs-877	102	15	in	in	ADP
iajs-877	102	16	grading	grade	VERB
iajs-877	102	17	,	,	PUNCT
iajs-877	102	18	staging	staging	NOUN
iajs-877	102	19	and	and	CCONJ
iajs-877	102	20	etiology	etiology	NOUN
iajs-877	102	21	of	of	ADP
iajs-877	102	22	chronic	chronic	ADJ
iajs-877	102	23	hepatitis	hepatitis	NOUN
iajs-877	102	24	"	"	PUNCT
iajs-877	102	25	a	a	DET
iajs-877	102	26	thesis	thesis	NOUN
iajs-877	102	27	fellowship	fellowship	NOUN
iajs-877	102	28	iraq	iraq	PROPN
iajs-877	102	29	commission	commission	PROPN
iajs-877	102	30	for	for	ADP
iajs-877	102	31	medical	medical	ADJ
iajs-877	102	32	specialization	specialization	NOUN
iajs-877	102	33	in	in	ADP
iajs-877	102	34	pathology	pathology	NOUN
iajs-877	102	35	.	.	PUNCT
iajs-877	103	1	13rahi	13rahi	NUM
iajs-877	103	2	,	,	PUNCT
iajs-877	103	3	s.j	s.j	PROPN
iajs-877	103	4	.	.	PROPN
iajs-877	103	5	(	(	PUNCT
iajs-877	103	6	2003	2003	NUM
iajs-877	103	7	)	)	PUNCT
iajs-877	103	8	.	.	PUNCT
iajs-877	103	9	"	"	PUNCT
iajs-877	104	1	cy	cy	INTJ
iajs-877	104	2	tokines	tokine	NOUN
iajs-877	104	3	profile	profile	NOUN
iajs-877	104	4	in	in	ADP
iajs-877	104	5	iraqi	iraqi	ADJ
iajs-877	104	6	patients	patient	NOUN
iajs-877	104	7	infected	infect	VERB
iajs-877	104	8	with	with	ADP
iajs-877	104	9	hcv	hcv	PROPN
iajs-877	104	10	"	"	PUNCT
iajs-877	104	11	m.sc	m.sc	PROPN
iajs-877	104	12	.	.	PUNCT
iajs-877	105	1	thesis	thesis	PROPN
iajs-877	105	2	college	college	PROPN
iajs-877	105	3	of	of	ADP
iajs-877	105	4	medicine	medicine	NOUN
iajs-877	105	5	/university	/university	PUNCT
iajs-877	105	6	of	of	ADP
iajs-877	105	7	baghdad	baghdad	PROPN
iajs-877	105	8	.	.	PUNCT
iajs-877	106	1	ibn	ibn	PROPN
iajs-877	106	2	alhaitham	alhaitham	PROPN
iajs-877	107	1	j.	j.	PROPN
iajs-877	108	1	fo	fo	ADP
iajs-877	108	2	r	r	NOUN
iajs-877	108	3	pure	pure	ADJ
iajs-877	108	4	&	&	CCONJ
iajs-877	108	5	appl	appl	PROPN
iajs-877	108	6	.	.	PUNCT
iajs-877	109	1	sci	sci	PROPN
iajs-877	109	2	.	.	PROPN
iajs-877	110	1	vo	vo	INTJ
iajs-877	111	1	l.24	l.24	PROPN
iajs-877	111	2	(	(	PUNCT
iajs-877	111	3	1	1	NUM
iajs-877	111	4	)	)	PUNCT
iajs-877	111	5	2011	2011	NUM
iajs-877	111	6	14saadet	14saadet	NUM
iajs-877	111	7	,	,	PUNCT
iajs-877	111	8	a.	a.	NOUN
iajs-877	111	9	;	;	PUNCT
iajs-877	111	10	erensoy	erensoy	NOUN
iajs-877	111	11	,	,	PUNCT
iajs-877	111	12	a.	a.	NOUN
iajs-877	111	13	;	;	PUNCT
iajs-877	111	14	elkran	elkran	VERB
iajs-877	111	15	,	,	PUNCT
iajs-877	111	16	o.	o.	PROPN
iajs-877	111	17	;	;	PUNCT
iajs-877	111	18	kurt	kurt	PROPN
iajs-877	111	19	,	,	PUNCT
iajs-877	111	20	a.	a.	NOUN
iajs-877	111	21	;	;	PUNCT
iajs-877	111	22	nese	nese	PROPN
iajs-877	111	23	setak	setak	PROPN
iajs-877	111	24	kurt	kurt	PROPN
iajs-877	111	25	,	,	PUNCT
iajs-877	111	26	a.and	a.and	CCONJ
iajs-877	111	27	denizmen	denizman	NOUN
iajs-877	111	28	aygün	aygün	NOUN
iajs-877	111	29	,	,	PUNCT
iajs-877	111	30	a.	a.	NOUN
iajs-877	111	31	2008	2008	NUM
iajs-877	111	32	,	,	PUNCT
iajs-877	111	33	hematological	hematological	ADJ
iajs-877	111	34	abnormalities	abnormality	NOUN
iajs-877	111	35	and	and	CCONJ
iajs-877	111	36	acute	acute	ADJ
iajs-877	111	37	viral	viral	ADJ
iajs-877	111	38	hepatitis	hepatitis	NOUN
iajs-877	111	39	a	a	NOUN
iajs-877	111	40	and	and	CCONJ
iajs-877	111	41	b	b	NOUN
iajs-877	111	42	,	,	PUNCT
iajs-877	111	43	j	j	PROPN
iajs-877	111	44	pediatr	pediatr	PROPN
iajs-877	111	45	inf	inf	PROPN
iajs-877	111	46	;	;	PUNCT
iajs-877	111	47	3	3	NUM
iajs-877	111	48	:	:	SYM
iajs-877	111	49	90	90	NUM
iajs-877	111	50	-	-	SYM
iajs-877	111	51	5	5	NUM
iajs-877	111	52	.	.	PUNCT
iajs-877	111	53	15siagris	15siagris	NUM
iajs-877	111	54	,	,	PUNCT
iajs-877	111	55	d.	d.	PROPN
iajs-877	111	56	;	;	PUNCT
iajs-877	111	57	vafiadis	vafiadis	PROPN
iajs-877	111	58	,	,	PUNCT
iajs-877	111	59	g.	g.	PROPN
iajs-877	111	60	;	;	PUNCT
iajs-877	111	61	michalaki	michalaki	NOUN
iajs-877	111	62	,	,	PUNCT
iajs-877	111	63	m.	m.	NOUN
iajs-877	111	64	;	;	PUNCT
iajs-877	111	65	lekkou	lekkou	PROPN
iajs-877	111	66	,	,	PUNCT
iajs-877	111	67	a.	a.	NOUN
iajs-877	111	68	;	;	PUNCT
iajs-877	111	69	starakis	starakis	PROPN
iajs-877	111	70	,	,	PUNCT
iajs-877	111	71	i.	i.	PROPN
iajs-877	111	72	;	;	PUNCT
iajs-877	111	73	makri	makri	PROPN
iajs-877	111	74	,	,	PUNCT
iajs-877	111	75	m.	m.	NOUN
iajs-877	111	76	;	;	PUNCT
iajs-877	111	77	margaritis	margaritis	ADJ
iajs-877	111	78	,	,	PUNCT
iajs-877	111	79	v.	v.	ADP
iajs-877	111	80	christofidou	christofidou	NOUN
iajs-877	111	81	,	,	PUNCT
iajs-877	111	82	m.	m.	NOUN
iajs-877	111	83	;	;	PUNCT
iajs-877	111	84	tsamandas	tsamandas	PROPN
iajs-877	111	85	,	,	PUNCT
iajs-877	111	86	a.	a.	NOUN
iajs-877	111	87	and	and	CCONJ
iajs-877	111	88	labropoulou	labropoulou	NOUN
iajs-877	111	89	-	-	PUNCT
iajs-877	111	90	karatza	karatza	PROPN
iajs-877	111	91	,	,	PUNCT
iajs-877	111	92	c.	c.	PROPN
iajs-877	111	93	(	(	PUNCT
iajs-877	111	94	2007),serum	2007),serum	NUM
iajs-877	111	95	adiponectin	adiponectin	NOUN
iajs-877	111	96	in	in	ADP
iajs-877	111	97	chronic	chronic	ADJ
iajs-877	111	98	hepatitis	hepatitis	NOUN
iajs-877	111	99	c	c	PROPN
iajs-877	111	100	and	and	CCONJ
iajs-877	111	101	b	b	PROPN
iajs-877	111	102	j	j	PROPN
iajs-877	111	103	viral	viral	ADJ
iajs-877	111	104	hepat	hepat	NOUN
iajs-877	111	105	.	.	PUNCT
iajs-877	112	1	;	;	PUNCT
iajs-877	112	2	14(8):577	14(8):577	NUM
iajs-877	112	3	-	-	SYM
iajs-877	112	4	583	583	NUM
iajs-877	112	5	.	.	PUNCT
iajs-877	113	1	16	16	NUM
iajs-877	113	2	-	-	PUNCT
iajs-877	113	3	jamal	jamal	PROPN
iajs-877	113	4	,	,	PUNCT
iajs-877	113	5	m.m	m.m	PROPN
iajs-877	113	6	.	.	PROPN
iajs-877	113	7	;	;	PUNCT
iajs-877	113	8	son	son	PROPN
iajs-877	113	9	,	,	PUNCT
iajs-877	113	10	a.	a.	PROPN
iajs-877	113	11	;	;	PUNCT
iajs-877	113	12	quinn	quinn	PROPN
iajs-877	113	13	,	,	PUNCT
iajs-877	113	14	p.g	p.g	PROPN
iajs-877	113	15	.	.	PROPN
iajs-877	113	16	;	;	PUNCT
iajs-877	113	17	wheeler	wheeler	NOUN
iajs-877	113	18	,	,	PUNCT
iajs-877	113	19	d.e	d.e	PROPN
iajs-877	113	20	.	.	PROPN
iajs-877	113	21	;	;	PUNCT
iajs-877	113	22	arora	arora	PROPN
iajs-877	113	23	,	,	PUNCT
iajs-877	113	24	s.and	s.and	PROPN
iajs-877	113	25	johonston	johonston	PROPN
iajs-877	113	26	,	,	PUNCT
iajs-877	113	27	d.	d.	PROPN
iajs-877	113	28	(	(	PUNCT
iajs-877	113	29	1999),clinical	1999),clinical	ADJ
iajs-877	113	30	features	feature	NOUN
iajs-877	113	31	of	of	ADP
iajs-877	113	32	hepatitis	hepatitis	PROPN
iajs-877	113	33	c	c	NOUN
iajs-877	113	34	-	-	PUNCT
iajs-877	113	35	infected	infect	VERB
iajs-877	113	36	patients	patient	NOUN
iajs-877	113	37	with	with	ADP
iajs-877	113	38	persistently	persistently	ADV
iajs-877	113	39	normal	normal	ADJ
iajs-877	113	40	alanine	alanine	NOUN
iajs-877	113	41	transaminase	transaminase	NOUN
iajs-877	113	42	levels	level	NOUN
iajs-877	113	43	in	in	ADP
iajs-877	113	44	the	the	DET
iajs-877	113	45	southwest	southwest	PROPN
iajs-877	113	46	united	united	PROPN
iajs-877	113	47	states	states	PROPN
iajs-877	113	48	.	.	PUNCT
iajs-877	114	1	hepatology	hepatology	NOUN
iajs-877	114	2	;	;	PUNCT
iajs-877	114	3	30:1307	30:1307	NUM
iajs-877	114	4	-	-	SYM
iajs-877	114	5	1311	1311	NUM
iajs-877	114	6	.	.	PUNCT
iajs-877	115	1	17sabry	17sabry	NUM
iajs-877	115	2	,	,	PUNCT
iajs-877	115	3	a.	a.	NOUN
iajs-877	115	4	;	;	PUNCT
iajs-877	115	5	el	el	PROPN
iajs-877	115	6	-	-	PUNCT
iajs-877	115	7	dahshan	dahshan	PROPN
iajs-877	115	8	,	,	PUNCT
iajs-877	115	9	k.	k.	PROPN
iajs-877	115	10	;	;	PUNCT
iajs-877	115	11	mahmoud	mahmoud	PROPN
iajs-877	115	12	,	,	PUNCT
iajs-877	115	13	k.	k.	PROPN
iajs-877	115	14	;	;	PUNCT
iajs-877	115	15	el	el	PROPN
iajs-877	115	16	-	-	PUNCT
iajs-877	115	17	husseini	husseini	PROPN
iajs-877	115	18	,	,	PUNCT
iajs-877	115	19	a.	a.	NOUN
iajs-877	115	20	;	;	PUNCT
iajs-877	115	21	sheashaa	sheashaa	PROPN
iajs-877	115	22	,	,	PUNCT
iajs-877	115	23	h.and	h.and	CCONJ
iajs-877	115	24	abo	abo	PROPN
iajs-877	115	25	-	-	PUNCT
iajs-877	115	26	zenah	zenah	NOUN
iajs-877	115	27	h.(2007	h.(2007	NOUN
iajs-877	115	28	)	)	PUNCT
iajs-877	115	29	,	,	PUNCT
iajs-877	115	30	.	.	PUNCT
iajs-877	116	1	effect	effect	NOUN
iajs-877	116	2	of	of	ADP
iajs-877	116	3	hepatitis	hepatitis	PROPN
iajs-877	116	4	c	c	PROPN
iajs-877	116	5	virus	virus	NOUN
iajs-877	116	6	on	on	ADP
iajs-877	116	7	hematocrit	hematocrit	PROPN
iajs-877	116	8	and	and	CCONJ
iajs-877	116	9	hemoglobin	hemoglobin	NOUN
iajs-877	116	10	levels	level	NOUN
iajs-877	116	11	in	in	ADP
iajs-877	116	12	egyptian	egyptian	ADJ
iajs-877	116	13	hemodailysis	hemodailysis	NOUN
iajs-877	116	14	patients	patient	NOUN
iajs-877	116	15	european	european	PROPN
iajs-877	116	16	journal	journal	PROPN
iajs-877	116	17	of	of	ADP
iajs-877	116	18	general	general	ADJ
iajs-877	116	19	medicine	medicine	NOUN
iajs-877	116	20	,	,	PUNCT
iajs-877	116	21	vol	vol	NOUN
iajs-877	116	22	.	.	PROPN
iajs-877	117	1	4	4	NUM
iajs-877	117	2	,	,	PUNCT
iajs-877	117	3	no	no	INTJ
iajs-877	117	4	.	.	NOUN
iajs-877	117	5	1	1	NUM
iajs-877	117	6	:	:	SYM
iajs-877	117	7	9	9	NUM
iajs-877	117	8	-	-	SYM
iajs-877	117	9	15	15	NUM
iajs-877	117	10	.	.	PUNCT
iajs-877	118	1	18papatheodoridis	18papatheodoridis	NUM
iajs-877	118	2	,	,	PUNCT
iajs-877	118	3	g.	g.	PROPN
iajs-877	118	4	;	;	PUNCT
iajs-877	118	5	papakonstantinou	papakonstantinou	PROPN
iajs-877	118	6	,	,	PUNCT
iajs-877	118	7	e.	e.	PROPN
iajs-877	118	8	;	;	PUNCT
iajs-877	118	9	andrioti	andrioti	PROPN
iajs-877	118	10	,	,	PUNCT
iajs-877	118	11	e.	e.	PROPN
iajs-877	118	12	;	;	PUNCT
iajs-877	118	13	cholongitas	cholongitas	PROPN
iajs-877	118	14	,	,	PUNCT
iajs-877	118	15	e.	e.	PROPN
iajs-877	118	16	;	;	PUNCT
iajs-877	118	17	petraki	petraki	PROPN
iajs-877	118	18	,	,	PUNCT
iajs-877	118	19	k.	k.	PROPN
iajs-877	118	20	;	;	PUNCT
iajs-877	118	21	kontopoulou	kontopoulou	PROPN
iajs-877	118	22	,	,	PUNCT
iajs-877	118	23	i.and	i.and	PRON
iajs-877	118	24	hadziyannis	hadziyannis	PROPN
iajs-877	118	25	,	,	PUNCT
iajs-877	118	26	s.	s.	PROPN
iajs-877	118	27	2003,thrombotic	2003,thrombotic	ADJ
iajs-877	118	28	risk	risk	NOUN
iajs-877	118	29	factors	factor	NOUN
iajs-877	118	30	and	and	CCONJ
iajs-877	118	31	extent	extent	NOUN
iajs-877	118	32	of	of	ADP
iajs-877	118	33	liver	liver	NOUN
iajs-877	118	34	fibrosis	fibrosis	NOUN
iajs-877	118	35	in	in	ADP
iajs-877	118	36	chronic	chronic	ADJ
iajs-877	118	37	viral	viral	ADJ
iajs-877	118	38	hepatitis	hepatitis	NOUN
iajs-877	118	39	.	.	PUNCT
iajs-877	119	1	gut;52:404–409	gut;52:404–409	PROPN
iajs-877	119	2	.	.	PUNCT
iajs-877	119	3	table	table	NOUN
iajs-877	119	4	(	(	PUNCT
iajs-877	119	5	1	1	NUM
iajs-877	119	6	):	):	PUNCT
iajs-877	119	7	demographic	demographic	ADJ
iajs-877	119	8	characteristics	characteristic	NOUN
iajs-877	119	9	of	of	ADP
iajs-877	119	10	cases	case	NOUN
iajs-877	119	11	hbv	hbv	NOUN
iajs-877	119	12	hcv	hcv	X
iajs-877	119	13	total	total	ADJ
iajs-877	119	14	number	number	NOUN
iajs-877	119	15	of	of	ADP
iajs-877	119	16	patient	patient	NOUN
iajs-877	119	17	(	(	PUNCT
iajs-877	119	18	%	%	NOUN
iajs-877	119	19	)	)	PUNCT
iajs-877	119	20	50	50	NUM
iajs-877	119	21	50	50	NUM
iajs-877	119	22	100	100	NUM
iajs-877	119	23	sex	sex	NOUN
iajs-877	119	24	male	male	NOUN
iajs-877	119	25	(	(	PUNCT
iajs-877	119	26	%	%	INTJ
iajs-877	119	27	)	)	PUNCT
iajs-877	119	28	36(72	36(72	ADJ
iajs-877	119	29	)	)	PUNCT
iajs-877	119	30	32(64	32(64	NUM
iajs-877	119	31	)	)	PUNCT
iajs-877	119	32	68(68	68(68	NUM
iajs-877	119	33	)	)	PUNCT
iajs-877	119	34	female	female	NOUN
iajs-877	119	35	(	(	PUNCT
iajs-877	119	36	%	%	NOUN
iajs-877	119	37	)	)	PUNCT
iajs-877	119	38	14(28	14(28	NUM
iajs-877	119	39	)	)	PUNCT
iajs-877	119	40	18(36	18(36	NUM
iajs-877	119	41	)	)	PUNCT
iajs-877	119	42	32(32	32(32	NUM
iajs-877	119	43	)	)	PUNCT
iajs-877	119	44	age	age	NOUN
iajs-877	119	45	(	(	PUNCT
iajs-877	119	46	mean±sd	mean±sd	PROPN
iajs-877	119	47	)	)	PUNCT
iajs-877	119	48	years	year	NOUN
iajs-877	119	49	(	(	PUNCT
iajs-877	119	50	min	min	PROPN
iajs-877	119	51	max	max	PROPN
iajs-877	119	52	)	)	PUNCT
iajs-877	119	53	36.9	36.9	NUM
iajs-877	119	54	±	±	NUM
iajs-877	119	55	15.8	15.8	NUM
iajs-877	119	56	11	11	NUM
iajs-877	119	57	65	65	NUM
iajs-877	119	58	39.9	39.9	NUM
iajs-877	119	59	±14.2	±14.2	NOUN
iajs-877	119	60	7	7	NUM
iajs-877	119	61	61	61	NUM
iajs-877	119	62	38.4±14.9	38.4±14.9	NUM
iajs-877	119	63	7	7	NUM
iajs-877	119	64	65	65	NUM
iajs-877	119	65	ibn	ibn	PROPN
iajs-877	119	66	alhaitham	alhaitham	NOUN
iajs-877	119	67	j.	j.	PROPN
iajs-877	120	1	fo	fo	ADP
iajs-877	120	2	r	r	NOUN
iajs-877	120	3	pure	pure	ADJ
iajs-877	120	4	&	&	CCONJ
iajs-877	120	5	appl	appl	PROPN
iajs-877	120	6	.	.	PUNCT
iajs-877	121	1	sci	sci	PROPN
iajs-877	121	2	.	.	PROPN
iajs-877	122	1	vo	vo	INTJ
iajs-877	122	2	l.24	l.24	PROPN
iajs-877	122	3	(	(	PUNCT
iajs-877	122	4	1	1	NUM
iajs-877	122	5	)	)	PUNCT
iajs-877	122	6	2011	2011	NUM
iajs-877	122	7	table	table	NOUN
iajs-877	122	8	(	(	PUNCT
iajs-877	122	9	2	2	NUM
iajs-877	122	10	):	):	PUNCT
iajs-877	122	11	levels	level	NOUN
iajs-877	122	12	of	of	ADP
iajs-877	122	13	liver	liver	NOUN
iajs-877	122	14	function	function	NOUN
iajs-877	122	15	tests	test	NOUN
iajs-877	122	16	in	in	ADP
iajs-877	122	17	chronic	chronic	ADJ
iajs-877	122	18	hbv	hbv	NOUN
iajs-877	122	19	,	,	PUNCT
iajs-877	122	20	hcv	hcv	VERB
iajs-877	122	21	patients	patient	NOUN
iajs-877	122	22	and	and	CCONJ
iajs-877	122	23	control	control	NOUN
iajs-877	122	24	.	.	PUNCT
iajs-877	123	1	ns=	ns=	VERB
iajs-877	123	2	non	non	ADJ
iajs-877	123	3	significant	significant	ADJ
iajs-877	123	4	,	,	PUNCT
iajs-877	123	5	s	s	NOUN
iajs-877	123	6	=	=	ADJ
iajs-877	123	7	significant	significant	ADJ
iajs-877	123	8	table	table	NOUN
iajs-877	123	9	(	(	PUNCT
iajs-877	123	10	3	3	NUM
iajs-877	123	11	):	):	PUNCT
iajs-877	123	12	total	total	ADJ
iajs-877	123	13	wbc	wbc	NOUN
iajs-877	123	14	count	count	NOUN
iajs-877	123	15	and	and	CCONJ
iajs-877	123	16	hemoglobulin	hemoglobulin	ADJ
iajs-877	123	17	concentration	concentration	NOUN
iajs-877	123	18	in	in	ADP
iajs-877	123	19	hbv	hbv	NOUN
iajs-877	123	20	,	,	PUNCT
iajs-877	123	21	hcv	hcv	VERB
iajs-877	123	22	patients	patient	NOUN
iajs-877	123	23	and	and	CCONJ
iajs-877	123	24	control	control	NOUN
iajs-877	123	25	.	.	PUNCT
iajs-877	124	1	ns=	ns=	VERB
iajs-877	124	2	non	non	ADJ
iajs-877	124	3	significant	significant	ADJ
iajs-877	124	4	,	,	PUNCT
iajs-877	124	5	s	s	NOUN
iajs-877	124	6	=	=	ADJ
iajs-877	124	7	significant	significant	ADJ
iajs-877	124	8	test	test	NOUN
iajs-877	124	9	hbv	hbv	NOUN
iajs-877	124	10	hcv	hcv	PROPN
iajs-877	124	11	control	control	NOUN
iajs-877	124	12	p	p	NOUN
iajs-877	124	13	-	-	PUNCT
iajs-877	124	14	value	value	NOUN
iajs-877	124	15	*	*	NOUN
iajs-877	124	16	total	total	ADJ
iajs-877	124	17	bilirubine	bilirubine	NOUN
iajs-877	124	18	(	(	PUNCT
iajs-877	124	19	mean	mean	INTJ
iajs-877	124	20	,	,	PUNCT
iajs-877	124	21	mg	mg	PROPN
iajs-877	124	22	/	/	SYM
iajs-877	124	23	dl	dl	NOUN
iajs-877	124	24	)	)	PUNCT
iajs-877	124	25	4.1	4.1	NUM
iajs-877	124	26	±	±	NUM
iajs-877	124	27	3.1	3.1	NUM
iajs-877	124	28	4.2	4.2	NUM
iajs-877	124	29	±	±	NUM
iajs-877	124	30	3	3	NUM
iajs-877	124	31	0.5±0.3	0.5±0.3	NUM
iajs-877	124	32	hbv*control	hbv*control	NOUN
iajs-877	124	33	=	=	NOUN
iajs-877	124	34	s	s	PART
iajs-877	124	35	hcv*control	hcv*control	NOUN
iajs-877	124	36	=	=	SYM
iajs-877	124	37	s	s	NOUN
iajs-877	124	38	hbv*hcv	hbv*hcv	NOUN
iajs-877	124	39	=	=	NOUN
iajs-877	124	40	ns	ns	ADJ
iajs-877	124	41	ast(iu	ast(iu	NOUN
iajs-877	124	42	/	/	SYM
iajs-877	124	43	l	l	NOUN
iajs-877	124	44	)	)	PUNCT
iajs-877	124	45	(	(	PUNCT
iajs-877	124	46	mean	mean	VERB
iajs-877	124	47	±	±	NUM
iajs-877	124	48	sd	sd	NOUN
iajs-877	124	49	)	)	PUNCT
iajs-877	124	50	37.8±	37.8±	NUM
iajs-877	124	51	10.4	10.4	NUM
iajs-877	124	52	41.6±	41.6±	NOUN
iajs-877	124	53	14.2	14.2	NUM
iajs-877	125	1	16±10.7	16±10.7	PROPN
iajs-877	125	2	hbv*control	hbv*control	NOUN
iajs-877	125	3	=	=	SYM
iajs-877	125	4	s	s	PART
iajs-877	125	5	hcv*control	hcv*control	NOUN
iajs-877	125	6	=	=	SYM
iajs-877	125	7	s	s	PART
iajs-877	125	8	hbv*hcv	hbv*hcv	NOUN
iajs-877	125	9	=	=	NOUN
iajs-877	125	10	ns	ns	NUM
iajs-877	125	11	alt	alt	ADJ
iajs-877	125	12	(	(	PUNCT
iajs-877	125	13	iu	iu	PROPN
iajs-877	125	14	/	/	SYM
iajs-877	125	15	l	l	NOUN
iajs-877	125	16	)	)	PUNCT
iajs-877	125	17	(	(	PUNCT
iajs-877	125	18	mean	mean	VERB
iajs-877	125	19	±	±	NUM
iajs-877	125	20	sd	sd	NOUN
iajs-877	125	21	)	)	PUNCT
iajs-877	125	22	55±40.8	55±40.8	PROPN
iajs-877	125	23	60.4±29.3	60.4±29.3	NUM
iajs-877	125	24	20±7.8	20±7.8	NUM
iajs-877	125	25	hbv*control	hbv*control	NOUN
iajs-877	125	26	=	=	SYM
iajs-877	125	27	s	s	PART
iajs-877	125	28	hcv*control	hcv*control	NOUN
iajs-877	125	29	=	=	SYM
iajs-877	125	30	s	s	NOUN
iajs-877	125	31	hbv*hcv	hbv*hcv	NOUN
iajs-877	125	32	=	=	NOUN
iajs-877	125	33	ns	ns	NUM
iajs-877	125	34	alp	alp	PROPN
iajs-877	125	35	(	(	PUNCT
iajs-877	125	36	iu	iu	PROPN
iajs-877	125	37	/	/	SYM
iajs-877	125	38	l	l	NOUN
iajs-877	125	39	)	)	PUNCT
iajs-877	125	40	(	(	PUNCT
iajs-877	125	41	mean	mean	VERB
iajs-877	125	42	±	±	NUM
iajs-877	125	43	sd	sd	NOUN
iajs-877	125	44	)	)	PUNCT
iajs-877	125	45	82.1±46.5	82.1±46.5	NUM
iajs-877	125	46	86.3±	86.3±	NOUN
iajs-877	125	47	44.7	44.7	NUM
iajs-877	125	48	40.6±9	40.6±9	NUM
iajs-877	126	1	hbv*control	hbv*control	NOUN
iajs-877	126	2	=	=	SYM
iajs-877	126	3	s	s	PART
iajs-877	126	4	hcv*control	hcv*control	NOUN
iajs-877	126	5	=	=	SYM
iajs-877	126	6	s	s	NOUN
iajs-877	126	7	hbv*hcv	hbv*hcv	NOUN
iajs-877	126	8	=	=	NOUN
iajs-877	126	9	ns	ns	ADJ
iajs-877	126	10	hbv	hbv	NOUN
iajs-877	126	11	hcv	hcv	PROPN
iajs-877	126	12	control	control	NOUN
iajs-877	126	13	p	p	NOUN
iajs-877	126	14	-	-	PUNCT
iajs-877	126	15	value	value	NOUN
iajs-877	126	16	total	total	NOUN
iajs-877	126	17	wbc	wbc	NOUN
iajs-877	126	18	count	count	NOUN
iajs-877	126	19	(	(	PUNCT
iajs-877	126	20	cell//mm3	cell//mm3	PROPN
iajs-877	126	21	)	)	PUNCT
iajs-877	126	22	(	(	PUNCT
iajs-877	126	23	mean±sd	mean±sd	ADP
iajs-877	126	24	6224	6224	NUM
iajs-877	126	25	±	±	NUM
iajs-877	126	26	1749.1	1749.1	NUM
iajs-877	126	27	4296±	4296±	NUM
iajs-877	126	28	1050.9	1050.9	NUM
iajs-877	126	29	7599±980	7599±980	NUM
iajs-877	126	30	hbv*contr	hbv*contr	NOUN
iajs-877	126	31	ol	ol	ADP
iajs-877	126	32	=	=	SYM
iajs-877	126	33	ns	ns	ADJ
iajs-877	126	34	hcv*contr	hcv*contr	NOUN
iajs-877	126	35	ol	ol	ADP
iajs-877	126	36	=	=	NOUN
iajs-877	126	37	s	s	NOUN
iajs-877	126	38	hbv*hcv	hbv*hcv	NOUN
iajs-877	126	39	=	=	NOUN
iajs-877	126	40	s	s	PART
iajs-877	126	41	hemoglobin	hemoglobin	NOUN
iajs-877	126	42	concentration	concentration	NOUN
iajs-877	126	43	(	(	PUNCT
iajs-877	126	44	g	g	NOUN
iajs-877	126	45	/	/	SYM
iajs-877	126	46	dl	dl	NOUN
iajs-877	126	47	)	)	PUNCT
iajs-877	126	48	(	(	PUNCT
iajs-877	126	49	mean±sd	mean±sd	ADP
iajs-877	126	50	13.4	13.4	NUM
iajs-877	126	51	±	±	NUM
iajs-877	126	52	1.3	1.3	NUM
iajs-877	126	53	10.9	10.9	NUM
iajs-877	126	54	±	±	NUM
iajs-877	126	55	2.2	2.2	NUM
iajs-877	126	56	13.8±1.9	13.8±1.9	NUM
iajs-877	126	57	hbv*contr	hbv*contr	NOUN
iajs-877	126	58	ol	ol	ADP
iajs-877	126	59	=	=	SYM
iajs-877	126	60	ns	ns	ADJ
iajs-877	126	61	hcv*contr	hcv*contr	NOUN
iajs-877	126	62	ol	ol	ADP
iajs-877	126	63	=	=	NOUN
iajs-877	126	64	s	s	NOUN
iajs-877	126	65	hbv*hcv	hbv*hcv	NOUN
iajs-877	126	66	=	=	NOUN
iajs-877	126	67	s	s	PART
iajs-877	126	68	ibn	ibn	PROPN
iajs-877	126	69	alhaitham	alhaitham	NOUN
iajs-877	126	70	j.	j.	PROPN
iajs-877	127	1	fo	fo	ADP
iajs-877	127	2	r	r	NOUN
iajs-877	127	3	pure	pure	ADJ
iajs-877	127	4	&	&	CCONJ
iajs-877	127	5	appl	appl	PROPN
iajs-877	127	6	.	.	PUNCT
iajs-877	128	1	sci	sci	PROPN
iajs-877	128	2	.	.	PROPN
iajs-877	129	1	vo	vo	INTJ
iajs-877	130	1	l.24	l.24	PROPN
iajs-877	130	2	(	(	PUNCT
iajs-877	130	3	1	1	NUM
iajs-877	130	4	)	)	PUNCT
iajs-877	130	5	2011	2011	NUM
iajs-877	130	6	hbv	hbv	NOUN
iajs-877	130	7	hcv	hcv	NOUN
iajs-877	130	8	control	control	NOUN
iajs-877	130	9	0	0	NUM
iajs-877	130	10	1000	1000	NUM
iajs-877	130	11	2000	2000	NUM
iajs-877	130	12	3000	3000	NUM
iajs-877	130	13	4000	4000	NUM
iajs-877	130	14	5000	5000	NUM
iajs-877	130	15	6000	6000	NUM
iajs-877	130	16	7000	7000	NUM
iajs-877	130	17	8000	8000	NUM
iajs-877	130	18	c	c	NOUN
iajs-877	130	19	e	e	NOUN
iajs-877	130	20	ll	ll	NOUN
iajs-877	130	21	/m	/m	VERB
iajs-877	130	22	3	3	NUM
iajs-877	130	23	fig	fig	NOUN
iajs-877	130	24	.	.	PUNCT
iajs-877	131	1	(	(	PUNCT
iajs-877	131	2	1):total	1):total	NUM
iajs-877	131	3	wbc	wbc	NOUN
iajs-877	131	4	count	count	NOUN
iajs-877	131	5	in	in	ADP
iajs-877	131	6	hbv	hbv	NOUN
iajs-877	131	7	,	,	PUNCT
iajs-877	131	8	hcv	hcv	VERB
iajs-877	131	9	patients	patient	NOUN
iajs-877	131	10	and	and	CCONJ
iajs-877	131	11	control	control	NOUN
iajs-877	131	12	.	.	PUNCT
iajs-877	132	1	hbv	hbv	PROPN
iajs-877	132	2	hcv	hcv	PROPN
iajs-877	132	3	control	control	NOUN
iajs-877	132	4	0	0	NUM
iajs-877	132	5	2	2	NUM
iajs-877	132	6	4	4	NUM
iajs-877	132	7	6	6	NUM
iajs-877	132	8	8	8	NUM
iajs-877	132	9	10	10	NUM
iajs-877	132	10	12	12	NUM
iajs-877	132	11	14	14	NUM
iajs-877	132	12	g	g	NOUN
iajs-877	132	13	/d	/d	PUNCT
iajs-877	132	14	l	l	NOUN
iajs-877	132	15	fig	fig	NOUN
iajs-877	132	16	.	.	PUNCT
iajs-877	133	1	(	(	PUNCT
iajs-877	133	2	2	2	NUM
iajs-877	133	3	):	):	PUNCT
iajs-877	133	4	hemoglobulin	hemoglobulin	ADJ
iajs-877	133	5	concentration	concentration	NOUN
iajs-877	133	6	in	in	ADP
iajs-877	133	7	hbv	hbv	NOUN
iajs-877	133	8	,	,	PUNCT
iajs-877	133	9	hcv	hcv	VERB
iajs-877	133	10	patients	patient	NOUN
iajs-877	133	11	and	and	CCONJ
iajs-877	133	12	control	control	NOUN
iajs-877	133	13	.	.	PUNCT
iajs-877	134	1	2011	2011	NUM
iajs-877	134	2	)	)	PUNCT
iajs-877	134	3	1	1	NUM
iajs-877	134	4	(	(	PUNCT
iajs-877	134	5	24المجلد	24المجلد	NUM
iajs-877	134	6	مجلة	مجلة	VERB
iajs-877	134	7	ابن	ابن	PROPN
iajs-877	134	8	الھیثم	الھیثم	PROPN
iajs-877	134	9	للعلوم	للعلوم	NOUN
iajs-877	134	10	الصرفة	الصرفة	PROPN
iajs-877	134	11	والتطبیقیة	والتطبیقیة	PROPN
iajs-877	134	12	لتهاب	لتهاب	PROPN
iajs-877	135	1	الكبد	الكبد	PROPN
iajs-877	135	2	امقارنة	امقارنة	PROPN
iajs-877	135	3	في	في	ADP
iajs-877	135	4	بعض	بعض	NOUN
iajs-877	135	5	الفحوصات	الفحوصات	ADJ
iajs-877	135	6	البایوكیمیائیة	البایوكیمیائیة	PROPN
iajs-877	135	7	وفحوصات	وفحوصات	PROPN
iajs-877	135	8	الدم	الدم	PROPN
iajs-877	135	9	بین	بین	PROPN
iajs-877	135	10	cو	cو	NOUN
iajs-877	135	11	bمن	bمن	PROPN
iajs-877	135	12	نوع	نوع	PROPN
iajs-877	135	13	الفایروسي	الفایروسي	PROPN
iajs-877	135	14	المز	المز	PROPN
iajs-877	135	15	رغد	رغد	PROPN
iajs-877	135	16	حسن	حسن	NOUN
iajs-877	135	17	حسین	حسین	VERB
iajs-877	135	18	كلیة	كلیة	PROPN
iajs-877	135	19	التقنیات	التقنیات	VERB
iajs-877	135	20	الصحیة	الصحیة	ADJ
iajs-877	135	21	والطبیة	والطبیة	X
iajs-877	135	22	الخالصة	الخالصة	PROPN
iajs-877	136	1	ة	ة	PRON
iajs-877	136	2	فــي	فــي	PROPN
iajs-877	136	3	العـالم	العـالم	PROPN
iajs-877	136	4	فایروسـيالتهـاب	فایروسـيالتهـاب	PROPN
iajs-877	136	5	الكبــد	الكبــد	PROPN
iajs-877	136	6	ال	ال	ADP
iajs-877	136	7	وأ	وأ	NOUN
iajs-877	136	8	bالتهــاب	bالتهــاب	PROPN
iajs-877	136	9	الكبـد	الكبـد	PROPN
iajs-877	136	10	الفایروســي	الفایروســي	PROPN
iajs-877	136	11	نــوع	نــوع	PROPN
iajs-877	136	12	إن	إن	PROPN
iajs-877	136	13	،	،	PROPN
iajs-877	136	14	اذ	اذ	PROPN
iajs-877	136	15	.	.	PROPN
iajs-877	136	16	المــزمن	المــزمن	PROPN
iajs-877	136	17	هـو	هـو	ADJ
iajs-877	136	18	مشــكلة	مشــكلة	ADJ
iajs-877	136	19	صــحیة	صــحیة	ADJ
iajs-877	136	20	مهمـ	مهمـ	NOUN
iajs-877	136	21	عینـة	عینـة	NOUN
iajs-877	136	22	دم	دم	ADP
iajs-877	136	23	لمرضـى	لمرضـى	NOUN
iajs-877	136	24	100تضـمنت	100تضـمنت	PROPN
iajs-877	136	25	الدراسـة	الدراسـة	PROPN
iajs-877	136	26	.	.	PUNCT
iajs-877	137	1	ة	ة	PRON
iajs-877	137	2	الكبدیالمسببة	الكبدیالمسببة	NOUN
iajs-877	137	3	لعدم	لعدم	ADJ
iajs-877	137	4	كفا	كفا	PROPN
iajs-877	137	5	الرئیسةمن	الرئیسةمن	PROPN
iajs-877	137	6	العوامل	العوامل	PROPN
iajs-877	137	7	هما	هما	PROPN
iajs-877	137	8	cالتهاب	cالتهاب	PROPN
iajs-877	137	9	الكبد	الكبد	PROPN
iajs-877	137	10	الفایروسي	الفایروسي	PROPN
iajs-877	137	11	نوع	نوع	VERB
iajs-877	137	12	ـنهم	ـنهم	PROPN
iajs-877	137	13	،	،	PROPN
iajs-877	137	14	یعـانون	یعـانون	PROPN
iajs-877	137	15	مــن	مــن	PROPN
iajs-877	137	16	التهــاب	التهــاب	PROPN
iajs-877	137	17	الكبــد	الكبــد	PROPN
iajs-877	137	18	الفایروســي	الفایروســي	PROPN
iajs-877	137	19	امریضــ	امریضــ	PROPN
iajs-877	137	20	50و	50و	PROPN
iajs-877	137	21	bنــوع	bنــوع	PROPN
iajs-877	137	22	المــزمن	المــزمن	PROPN
iajs-877	137	23	مصـابون	مصـابون	PROPN
iajs-877	137	24	بالتهــاب	بالتهــاب	NOUN
iajs-877	137	25	الكبــد	الكبــد	PROPN
iajs-877	137	26	الفایروســي	الفایروســي	PROPN
iajs-877	137	27	امریضــ	امریضــ	PROPN
iajs-877	137	28	50مـ	50مـ	PROPN
iajs-877	137	29	ن	ن	ADP
iajs-877	137	30	من	من	PRON
iajs-877	137	31	االشخاص	االشخاص	PROPN
iajs-877	137	32	األصـحاءالمطابقین	األصـحاءالمطابقین	PROPN
iajs-877	137	33	بـالعمر	بـالعمر	PROPN
iajs-877	137	34	والجـنس	والجـنس	PROPN
iajs-877	137	35	یتضمن	یتضمن	PROPN
iajs-877	137	36	البحث	البحث	PROPN
iajs-877	137	37	عشر	عشر	PROPN
iajs-877	137	38	.cنوع	.cنوع	PROPN
iajs-877	137	39	المزمن	المزمن	PROPN
iajs-877	137	40	الكبد	الكبد	PROPN
iajs-877	137	41	الفایروسي	الفایروسي	PROPN
iajs-877	137	42	بالتهابمصابون	بالتهابمصابون	VERB
iajs-877	137	43	من	من	DET
iajs-877	137	44	الـذكور	الـذكور	ADJ
iajs-877	137	45	%	%	NOUN
iajs-877	137	46	)	)	PUNCT
iajs-877	137	47	72	72	NUM
iajs-877	138	1	(	(	PUNCT
iajs-877	138	2	36كان	36كان	NUM
iajs-877	138	3	هناك	هناك	PROPN
iajs-877	138	4	bن	bن	PROPN
iajs-877	138	5	بالتهاب	بالتهاب	PROPN
iajs-877	138	6	الكبد	الكبد	PROPN
iajs-877	138	7	الفایروسي	الفایروسي	PROPN
iajs-877	138	8	نوع	نوع	PROPN
iajs-877	138	9	یمن	یمن	NOUN
iajs-877	138	10	الخمسین	الخمسین	PROPN
iajs-877	138	11	مریض	مریض	PROPN
iajs-877	138	12	المصابمن	المصابمن	PROPN
iajs-877	138	13	ض	ض	PROPN
iajs-877	138	14	.مجموعة	.مجموعة	PROPN
iajs-877	138	15	سیطرة	سیطرة	PRON
iajs-877	138	16	هـم	هـم	PROPN
iajs-877	138	17	مـن	مـن	NOUN
iajs-877	138	18	الـذكور	الـذكور	VERB
iajs-877	138	19	c	c	PROPN
iajs-877	138	20	من	من	PRON
iajs-877	138	21	المرضى	المرضى	PROPN
iajs-877	138	22	المصابون	المصابون	NOUN
iajs-877	138	23	بالتهاب	بالتهاب	PROPN
iajs-877	138	24	الكبد	الكبد	PROPN
iajs-877	138	25	الفایروسي	الفایروسي	PROPN
iajs-877	138	26	نـوع	نـوع	PROPN
iajs-877	138	27	%	%	NOUN
iajs-877	138	28	)	)	PUNCT
iajs-877	138	29	64(وثالثون	64(وثالثون	NUM
iajs-877	138	30	اثنان	اثنان	PROPN
iajs-877	138	31	.	.	PUNCT
iajs-877	139	1	اإلناثمن	اإلناثمن	PROPN
iajs-877	139	2	%	%	NOUN
iajs-877	139	3	)	)	PUNCT
iajs-877	140	1	28(14و	28(14و	NUM
iajs-877	140	2	±	±	NUM
iajs-877	140	3	39,9سـنة	39,9سـنة	NUM
iajs-877	140	4	و	و	NOUN
iajs-877	140	5	15,8	15,8	NUM
iajs-877	140	6	±	±	NOUN
iajs-877	140	7	36,9كـان	36,9كـان	NUM
iajs-877	140	8	bمعـدل	bمعـدل	NOUN
iajs-877	140	9	العمـر	العمـر	PROPN
iajs-877	140	10	لمرضـى	لمرضـى	PROPN
iajs-877	140	11	التهـاب	التهـاب	PROPN
iajs-877	140	12	الكبـد	الكبـد	PROPN
iajs-877	140	13	الفیروسـي	الفیروسـي	PROPN
iajs-877	140	14	نـوع	نـوع	PROPN
iajs-877	140	15	.	.	PUNCT
iajs-877	141	1	اإلنـاثمن	اإلنـاثمن	VERB
iajs-877	141	2	%	%	NOUN
iajs-877	141	3	)	)	PUNCT
iajs-877	142	1	63(18و	63(18و	NUM
iajs-877	142	2	نتـائج	نتـائج	NOUN
iajs-877	142	3	فحوصــات	فحوصــات	ADJ
iajs-877	142	4	وظــائف	وظــائف	PROPN
iajs-877	142	5	الكبـد	الكبـد	NOUN
iajs-877	142	6	أظهــرت	أظهــرت	PROPN
iajs-877	142	7	عــدم	عــدم	PROPN
iajs-877	142	8	وجـود	وجـود	PROPN
iajs-877	142	9	فــرق	فــرق	PROPN
iajs-877	142	10	معنــوي	معنــوي	PROPN
iajs-877	142	11	بــین	بــین	PROPN
iajs-877	142	12	.	.	PUNCT
iajs-877	143	1	cسـنة	cسـنة	PROPN
iajs-877	143	2	لمرضــى	لمرضــى	PROPN
iajs-877	143	3	التهــاب	التهــاب	PROPN
iajs-877	143	4	الكبـد	الكبـد	PROPN
iajs-877	143	5	الفیروســي	الفیروســي	PROPN
iajs-877	143	6	نــوع	نــوع	PROPN
iajs-877	143	7	14,2	14,2	PROPN
iajs-877	143	8	c	c	NOUN
iajs-877	143	9	والتهـاب	والتهـاب	VERB
iajs-877	143	10	الكبـد	الكبـد	PROPN
iajs-877	143	11	نـوع	نـوع	PROPN
iajs-877	143	12	bمرضـى	bمرضـى	PROPN
iajs-877	143	13	التهـاب	التهـاب	PROPN
iajs-877	143	14	الكبـد	الكبـد	PROPN
iajs-877	143	15	نـوع	نـوع	PROPN
iajs-877	144	1	أظهـر	أظهـر	PROPN
iajs-877	145	1	كـل	كـل	NOUN
iajs-877	145	2	مـن	مـن	NOUN
iajs-877	145	3	.cوالتهاب	.cوالتهاب	PUNCT
iajs-877	145	4	الكبـد	الكبـد	PROPN
iajs-877	145	5	نـوع	نـوع	PROPN
iajs-877	145	6	bمرضى	bمرضى	PROPN
iajs-877	145	7	التهاب	التهاب	PROPN
iajs-877	145	8	الكبد	الكبد	PROPN
iajs-877	145	9	نوع	نوع	PROPN
iajs-877	145	10	مجمـوع	مجمـوع	PROPN
iajs-877	145	11	في	في	ADP
iajs-877	145	12	حین	حین	PROPN
iajs-877	145	13	أظهـرت	أظهـرت	PROPN
iajs-877	145	14	النتـائج	النتـائج	NOUN
iajs-877	145	15	أن	أن	PROPN
iajs-877	145	16	.	.	PUNCT
iajs-877	146	1	فحوصات	فحوصات	PROPN
iajs-877	146	2	وظائف	وظائف	PROPN
iajs-877	147	1	الكبد	الكبد	PROPN
iajs-877	147	2	عند	عند	PROPN
iajs-877	147	3	مقارنتهم	مقارنتهم	VERB
iajs-877	147	4	بمجموعة	بمجموعة	PROPN
iajs-877	147	5	السیطرةلى	السیطرةلى	PROPN
iajs-877	147	6	اوجود	اوجود	PROPN
iajs-877	147	7	فرق	فرق	PROPN
iajs-877	147	8	معنوي	معنوي	PROPN
iajs-877	147	9	بالنسبة	بالنسبة	PROPN
iajs-877	147	10	ــاء	ــاء	PROPN
iajs-877	147	11	وتركیــز	وتركیــز	PROPN
iajs-877	147	12	الهیموغلــوبین	الهیموغلــوبین	PROPN
iajs-877	147	13	ـة1050,9±4296(كریــات	ـة1050,9±4296(كریــات	PROPN
iajs-877	147	14	الــدم	الــدم	PROPN
iajs-877	147	15	البیضـ	البیضـ	NOUN
iajs-877	147	16	كــان	كــان	PROPN
iajs-877	147	17	أقــل	أقــل	PROPN
iajs-877	147	18	فـــي	فـــي	PROPN
iajs-877	147	19	)	)	PUNCT
iajs-877	147	20	مـــل	مـــل	VERB
iajs-877	147	21	100	100	NUM
iajs-877	147	22	/	/	SYM
iajs-877	147	23	غــم	غــم	ADJ
iajs-877	147	24	2,2±10,9و	2,2±10,9و	NOUN
iajs-877	147	25	3ملــم/	3ملــم/	NUM
iajs-877	147	26	خلیــ	خلیــ	NOUN
iajs-877	147	27	100	100	NUM
iajs-877	147	28	/	/	SYM
iajs-877	147	29	غـم	غـم	NOUN
iajs-877	147	30	1,4±	1,4±	NUM
iajs-877	147	31	13,4و	13,4و	NOUN
iajs-877	147	32	3ملـم/	3ملـم/	NUM
iajs-877	147	33	خلیـةb	خلیـةb	NOUN
iajs-877	147	34	)	)	PUNCT
iajs-877	147	35	6224	6224	NUM
iajs-877	148	1	±1749,1	±1749,1	ADP
iajs-877	148	2	9من	9من	PROPN
iajs-877	148	3	مرضى	مرضى	PROPN
iajs-877	148	4	التهاب	التهاب	PROPN
iajs-877	148	5	الكبـد	الكبـد	PROPN
iajs-877	148	6	نـوع	نـوع	PROPN
iajs-877	148	7	cمرضى	cمرضى	PROPN
iajs-877	148	8	التهاب	التهاب	PROPN
iajs-877	148	9	الكبد	الكبد	PROPN
iajs-877	148	10	نوع	نوع	PROPN
iajs-877	148	11	مجموعـة	مجموعـة	NOUN
iajs-877	148	12	السـیطرة	السـیطرة	PROPN
iajs-877	148	13	فیمـا	فیمـا	PROPN
iajs-877	148	14	و	و	PRON
iajs-877	148	15	bمرضـى	bمرضـى	PROPN
iajs-877	148	16	التهـاب	التهـاب	PROPN
iajs-877	148	17	الكبـد	الكبـد	PROPN
iajs-877	148	18	نـوع	نـوع	PROPN
iajs-877	148	19	في	في	DET
iajs-877	148	20	حین	حین	NOUN
iajs-877	148	21	لم	لم	ADP
iajs-877	148	22	یكن	یكن	VERB
iajs-877	148	23	هناك	هناك	PROPN
iajs-877	148	24	فرق	فرق	NOUN
iajs-877	148	25	معنوي	معنوي	PROPN
iajs-877	148	26	بین	بین	PROPN
iajs-877	148	27	.	.	PUNCT
iajs-877	149	1	نوي	نوي	NOUN
iajs-877	149	2	مع	مع	INTJ
iajs-877	149	3	وجود	وجود	PROPN
iajs-877	149	4	فرق	فرق	PROPN
iajs-877	149	5	مع	مع	ADP
iajs-877	149	6	)	)	PUNCT
iajs-877	149	7	مل	مل	PROPN
iajs-877	149	8	.یخص	.یخص	PUNCT
iajs-877	150	1	مجموع	مجموع	PROPN
iajs-877	150	2	كریات	كریات	ADJ
iajs-877	150	3	الدم	الدم	PROPN
iajs-877	150	4	البیضاء	البیضاء	PROPN
iajs-877	150	5	وتركیز	وتركیز	PROPN
iajs-877	150	6	الهیموغلوبین	الهیموغلوبین	PROPN
iajs-877	150	7	فـي	فـي	PROPN
iajs-877	150	8	بعـض	بعـض	PROPN
iajs-877	150	9	فحوصـات	فحوصـات	PROPN
iajs-877	150	10	الــدم	الــدم	PROPN
iajs-877	151	1	c	c	PROPN
iajs-877	151	2	و	و	PRON
iajs-877	151	3	التهــاب	التهــاب	PROPN
iajs-877	151	4	الكبـد	الكبـد	PROPN
iajs-877	151	5	المـزمن	المـزمن	PROPN
iajs-877	151	6	bیهـدف	bیهـدف	PROPN
iajs-877	151	7	البحـث	البحـث	PROPN
iajs-877	151	8	إلـى	إلـى	PROPN
iajs-877	151	9	المقارنـة	المقارنـة	PROPN
iajs-877	151	10	بــین	بــین	VERB
iajs-877	151	11	التهـاب	التهـاب	PROPN
iajs-877	151	12	الكبـد	الكبـد	PROPN
iajs-877	151	13	المـزمن	المـزمن	PROPN
iajs-877	151	14	نـوع	نـوع	NOUN
iajs-877	151	15	.وبعض	.وبعض	PUNCT
iajs-877	151	16	فحوصات	فحوصات	PROPN
iajs-877	151	17	الكیمیاء	الكیمیاء	PROPN
iajs-877	152	1	الحیاتیة	الحیاتیة	PROPN
iajs-877	152	2	cو	cو	PROPN
iajs-877	152	3	bالتهاب	bالتهاب	PROPN
iajs-877	152	4	الكبد	الكبد	PROPN
iajs-877	152	5	الفایروسي	الفایروسي	PROPN
iajs-877	152	6	المزمن	المزمن	VERB
iajs-877	152	7	نوع	نوع	NOUN
iajs-877	152	8	:	:	PUNCT
iajs-877	152	9	الكلمات	الكلمات	VERB
iajs-877	152	10	المفتاحیة	المفتاحیة	ADV